case_id,mode,case_type,iteration,Q0_answer,Q0_reasoning,Q1_answer,Q1_reasoning,Q2_answer,Q2_reasoning,Q3_answer,Q3_reasoning,Q4_answer,Q4_reasoning,Q5_answer,Q5_reasoning,Q6_answer,Q6_reasoning,Q7_answer,Q7_reasoning,Q8_answer,Q8_reasoning,input_tokens,output_tokens,total_tokens
Case3223,rag,all_incorrect,iter1,BRCA1/2,The patient was referred specifically for BRCA1 and BRCA2 testing (stated in patient information).,Not Specified,The provided FEP policy (2.04.126) discusses CHEK2/ATM/BARD1 and references BRCA testing being described in a separate related policy (2.04.02) but does not state any age-based eligibility criteria for BRCA1/2 within the text provided.,Not Specified,The policy recommends genetic counseling by an experienced provider but does not specify formal ordering-provider specialty or other mandatory ordering-provider requirements for BRCA testing in the text provided.,Not Specified,"The policy references NCCN criteria and that BRCA1/2 testing strategy is in a separate review (2.04.02), but the provided document does not itself define specific medical indication criteria for BRCA1/2 testing, so specific clinical indications are not defined here.",Not Specified,The provided policy does not define any required prior diagnostic tests that must be completed before BRCA1/2 testing.,Yes,"The policy states that NCCN criteria for genetic risk evaluation (including individuals without personal breast cancer) apply and testing may be considered based on family history. The patient has a first-degree relative (sister) with epithelial ovarian cancer, which is relevant to hereditary breast/ovarian cancer risk per the policy references to NCCN.",Not Specified,"The policy strongly recommends formal genetic counseling and states it 'should' be performed by someone experienced, but it does not make documented pre-test genetic counseling an explicit mandatory coverage requirement in the provided text.",Not Specified,The provided policy document does not list or map CPT codes to BRCA1/2 testing; no CPT guidance is present in the text supplied.,No,"The provided policy (2.04.126) does not itself establish coverage criteria for BRCA1/2 (it refers to a different related policy for BRCA testing) and states that benefits are for testing that is medically necessary per established criteria (e.g., NCCN). There is insufficient documentation in the record (and in the provided policy text) to confirm the patient meets the required NCCN/medical-necessity criteria for BRCA testing; additionally there is no documented pre-test genetic counseling. Based solely on the provided policy text and patient facts, coverage cannot be affirmed, so the test is not covered.",10994,2647,13641
Case14226,rag,all_incorrect,iter1,BRCA1/2,Patient clinical information explicitly states germline BRCA1 and BRCA2 (BRCA1/2) testing is being pursued.,Not Specified,The provided Hereditary Cancer Syndrome panel policy does not state any age-based eligibility criteria for BRCA1/2 testing or multigene hereditary cancer testing.,Not Specified,The policy does not state a specific ordering provider specialty requirement for BRCA/multigene testing; it requires 'pre- and post-test genetic counseling by an appropriate provider' but does not specify required ordering provider type.,Not Answerable,"Coverage for panels requires the member meet 'criteria for BRCA Analysis based on current EviCore guideline BRCA Analysis'; that specific BRCA Analysis guideline text is not provided, so it cannot be determined from the provided policy whether this patient's clinical details meet those BRCA-specific criteria.",No,"The policy requires pre- and post-test genetic counseling as part of eligibility for hereditary cancer panel testing; the patient has not completed pre-test genetic counseling, so a required prerequisite was not completed.",No,"The policy uses family history to determine eligibility (eg, affected relatives, known mutation in family). The patient’s family history describes a mother with a hematologic/immunologic disorder but no relevant cancer family history or known cancer-predisposing mutation is documented, so the patient does not have the family history required for panel-specific family-based criteria.",No,The policy explicitly requires pre- and post-test genetic counseling by an appropriate provider for hereditary cancer panel testing; the patient did not have pre-test genetic counseling completed.,Not Specified,"The policy lists certain panel and laboratory-specific codes (e.g., BRCAplus 0129U, panel codes like 81432, 81479) but does not map BRCA1/2 single-gene testing to any of the provided CPT options (81162, 81277, 81228, 81415, 81425).",No,"Per the policy, pre-test genetic counseling is a required criterion for hereditary cancer panel testing and the patient has not completed pre-test counseling; additionally, coverage depends on meeting the BRCA Analysis criteria (which cannot be confirmed from the provided documents). Therefore coverage is not supported based on the provided policy and patient facts.",11927,2560,14487
Case10451,rag,all_incorrect,iter1,WES,Patient was referred for whole exome sequencing (WES) by neurology to evaluate unexplained neurodevelopmental disorder (stated in the patient information).,Yes,"Policy criterion I.A.2.a allows ES for nonsyndromic developmental delay or intellectual disability with onset prior to age 18. The patient is 10 years old with childhood-onset moderate–severe intellectual disability, meeting the age-related criterion.",No,Policy requires pre/post-test counseling by an appropriate provider and evaluation by a Board-Certified/Board-Eligible Medical Geneticist or APN in Genetics (Criteria F and G). The ordering provider is a neurologist and there is no documentation that the required geneticist/APGN evaluation or genetic counselor involvement occurred.,Yes,"Policy I.A.2.a lists apparently nonsyndromic developmental delay or intellectual disability with onset before age 18 as an indication for ES. The patient has moderate–severe intellectual disability of childhood onset, meeting this medical indication.",Not Specified,"The policy does not explicitly mandate prior testing (e.g., CMA) as a required absolute prior test in the criteria—although guidance notes ES is often considered after nondiagnostic CMA. The patient did have a nondiagnostic CMA, but the policy does not state CMA is strictly required.",No,"The policy specifies 'family history strongly suggestive of a genetic etiology, including consanguinity' as a possible criterion. The provided family history (a sibling with a brief resolved unexplained event) is not documented as 'strongly suggestive' of a genetic etiology per the policy definition.",No,"Policy requires pre- and post-test counseling by an appropriate provider (e.g., Board-Certified Medical Geneticist, Certified Genetic Counselor, or APN in Genetics). There is no documentation of prior genetic counseling for this patient.",81415,"Policy reference table lists 81415 as the common CPT code for standard exome sequencing (Exome - Proband), which corresponds to the requested WES for this proband.",No,"Although the patient meets age and medical indication (childhood-onset intellectual disability) and had nondiagnostic CMA, the policy requires pre/post-test genetic counseling and evaluation by a Board-Certified/Board-Eligible Medical Geneticist or APN in Genetics (Criteria F and G). These provider/counseling requirements are not met/documented (ordering provider is a neurologist and no counseling documented), therefore the request does not meet all required policy criteria for coverage.",12248,1900,14148
Case4196,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being requested.,Not Specified,The provided BCBS_FEP_20459 policy addresses CMA and NGS panels and states WES is addressed in a separate policy (2.04.102); no age-based eligibility criteria for WES are specified in this document.,Not Specified,The policy discusses genetic counseling and specialists for interpretation but does not specify ordering-provider (specialty/type) requirements for WES in this document.,Not Specified,"This policy defines medical indications for CMA (eg, apparently nonsyndromic developmental delay/ID) and states NGS panels are investigational; it does not define medical necessity criteria for WES (WES is referenced as addressed in a separate policy).",Not Specified,"The policy describes CMA as first-line and mentions stepwise approaches (eg, fragile X and CMA first, then further testing if diagnosis not established), but it does not state explicit required prior testing for WES in this document.",Not Specified,"While the patient has a relevant family history (affected brother), the provided policy does not specify family history or consanguinity criteria for WES eligibility within this document.",Not Answerable,"The policy recommends formal genetic counseling by experienced individuals for genetic testing generally and notes counseling should be performed by someone with expertise; the patient has completed pre-test counseling, but the record does not state the counselor's qualifications required by the policy, so adequacy relative to policy requirements cannot be confirmed from the provided information.",81415,"The requested test is whole exome sequencing (WES); among the provided CPT options, 81415 corresponds to exome sequencing.",No,"The provided policy (FEP 2.04.59) does not establish coverage criteria for WES (it states WES is addressed in a separate policy 2.04.102) and labels NGS panel testing investigational; because WES coverage criteria are not specified in this document and are handled elsewhere, coverage cannot be confirmed under this policy, so it is not covered based on the provided policy text.",15710,2141,17851
Case18281,rag,all_incorrect,iter1,WGS,Patient clinical info states the cardiologist has ordered whole genome sequencing (WGS).,Yes,"Policy M2032 specifies age <18 for evaluation of unexplained congenital disorders (WES/WGS pathway); patient is 6 years old, meeting the age criterion.",No,"Policy II.1(a) requires evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor prior to WES (and WGS is only covered after WES per II.4). The ordering provider is a cardiologist and no genetics evaluation/counseling was done, so provider requirements are not met.",Yes,"Policy indicates WES/WGS is indicated for unexplained congenital anomalies in <18 yo when a genomic etiology is likely and presentation does not fit a well-described syndrome; the patient has multiple congenital anomalies not fitting a defined syndrome and a sibling with an inborn error of metabolism, meeting the clinical indication component.",No,"Policy II.4 states WGS MEETS COVERAGE CRITERIA only when WES is unable to identify a causative mutation (i.e., prior WES required). The patient has had Fragile X testing only and no WES performed, so required prior testing has not been completed.",Yes,"Policy supports use of sequencing when a genomic etiology/family history suggests genetic disease; the patient has a sibling with an inborn error of metabolism, which is relevant to eligibility under the policy's genomic-etiology considerations.",No,"Policy II.1(a) requires pre-test counseling by an ABMGG geneticist or an ABGC genetic counselor for pediatric WES (and WGS coverage is contingent on WES pathway). The patient had no genetic counseling prior to testing, so counseling requirements are not met.",Not Specified,The provided policy text (M2032) does not list or map CPT codes to WES/WGS; therefore a specific CPT code cannot be determined from the document.,No,"Under Policy M2032 WGS is covered only when WES has been performed and failed to identify a causative mutation and all WES criteria are met (including genetics evaluation and counseling). The patient has not had WES, has no pre-test genetics counseling, and the order is directly for WGS by a cardiologist; therefore WGS does not meet the policy's coverage criteria.",22469,2575,25044
Case17196,rag,all_incorrect,iter1,CMA,Patient information explicitly states the test requested is chromosomal microarray (CMA) testing.,Not Specified,The policy contains general age language for adult-onset risk assessments (must be ≥ age of majority for asymptomatic adult-onset testing) but does not specify an age limit or specific age-based eligibility for CMA; the patient is 63 but no CMA-specific age criteria are provided in the policy.,No,"Policy I.1 states genetic counseling is required prior to testing unless the test is ordered by a specialist in the disease process. The CMA is being requested for a neuropsychiatric indication by an oncologist (not a specialist in neuropsychiatric disease), so the ordering circumstances do not meet the policy exemption and the ordering/provider requirements are not satisfied.",No,"The policy requires symptomatic individuals to have suspicion of a known genetic disease where mutation knowledge will assist diagnosis/treatment/procreative management and that testing has clinical utility. While the patient is symptomatic with neuropsychiatric features and had a nondiagnostic karyotype, the policy requires evidence that mutation knowledge is clinically actionable and will impact management; the documentation does not demonstrate that criterion is met for this neuropsychiatric CMA request.",Not Specified,"The policy does not define specific prerequisite prior tests that must be completed before CMA; it only generally states other testing should be equivocal or not exist as part of demonstrating need, but no explicit required prior test sequence for CMA is specified.",Not Specified,"The policy references family history as relevant for asymptomatic risk assessment but does not define specific family-history/consanguinity criteria for CMA in this clinical scenario. Although the patient has a sibling with early sensory impairment, the policy does not specifically state this family history makes CMA eligible.",No,"Policy I.1 explicitly states genetic counseling meets coverage criteria and is required prior to testing unless testing is ordered by a specialist in the disease process. The patient has had no pre-test genetic counseling and the ordering provider (oncologist for a neuropsychiatric indication) does not qualify as that disease-specialist exemption, so counseling requirements are not met.",Not Specified,The policy's reimbursement section discusses use of appropriate molecular pathology codes and examples but does not specify a CPT code for chromosomal microarray (CMA); none of the listed CPT options are specified in the policy text for CMA.,No,"Per the policy, testing must meet clinical utility criteria and required pre-test genetic counseling must be completed (unless ordered by a disease specialist). The documentation does not demonstrate that CMA will meet the policy's clinical utility/actionability requirements for this neuropsychiatric indication, and required pre-test genetic counseling was not performed (ordering provider does not meet the specialist exemption). Therefore coverage is not met under the policy.",10242,2655,12897
Case8288,rag,all_incorrect,iter1,WES,Patient information states whole exome sequencing (WES) is being pursued to evaluate the fetal congenital cardiac anomaly; WES is explicitly requested.,Not Specified,"The policy's WES age-based criteria apply to children/infants; the policy explicitly states it does not address prenatal (fetal) testing, so age-based eligibility for this fetal case is not specified in the policy.",Not Answerable,"The policy requires evaluation by a clinician with expertise in clinical genetics (documentation required). The record notes referral and genetic counseling sessions but does not explicitly document evaluation by a clinician with expertise in clinical genetics, so adequacy of the ordering provider cannot be confirmed from the provided information.",Not Specified,"The policy defines medical indications for WES in children with unexplained congenital anomalies, but it explicitly does not address prenatal (fetal) testing; therefore applicable clinical indications for this fetal scenario are not specified in the policy.",Yes,"Policy criterion requires prior relevant genetic testing (eg, chromosomal microarray) or that prior testing failed to yield a diagnosis. The patient had a chromosomal microarray (CMA) previously performed and nondiagnostic, meeting the prior-test requirement.",Yes,"The policy lists family history of an inborn error of metabolism as relevant; the patient has family history of an inborn error of metabolism affecting an older sibling, which is a specified relevant family history.",Yes,"The policy requires counseling about potential risks by someone with genetics expertise. The record states the parents have had multiple sessions with a genetic counselor, satisfying the counseling requirement documented in the policy.",81415,The requested test is whole exome sequencing (WES); CPT code 81415 corresponds to clinical exome (whole exome) sequencing.,No,"Although WES is covered for children with unexplained congenital anomalies per the policy, the policy explicitly states it does not address prenatal (fetal) testing. Because the request is for a fetus (prenatal), the policy does not provide medical necessity criteria for coverage of prenatal WES, so it is not covered under this policy.",14871,2195,17066
Case3422,rag,all_incorrect,iter1,WES,Patient information explicitly states consideration of whole-exome sequencing (WES).,Not Specified,The policy does not impose a general age cutoff for standard exome sequencing; age-specific limits are given only for rapid exome (infants ≤12 months) or for developmental-delay onset <18 yrs. The patient is 34 and no policy age exclusion for standard WES is specified.,No,"Policy requires evaluation by a Board-Certified or Board-Eligible Medical Geneticist or an Advanced Practice Nurse in Genetics for standard ES (criteria I.G). Patient info documents multiple visits with a genetic counselor but does not state evaluation by a Medical Geneticist or APGN, so ordering/provider requirements are not met per the policy.",No,"Standard ES is covered when etiology unknown and genetics likely based on (a) developmental delay with onset <18, OR (b) multiple congenital abnormalities affecting unrelated organ systems, OR (c) TWO listed features (e.g., single-organ abnormality plus another). Patient has a single congenital choanal atresia (one organ system) and no additional qualifying features documented, so she does not meet the defined medical indications in the policy.",Not Specified,"The policy advises consideration of ES after unrevealing testing (e.g., CMA) but does not mandate a specific prior test as a universal requirement in the formal criteria. Although the patient had a nondiagnostic CMA, the policy does not explicitly require CMA completion as a prerequisite.",No,"The policy lists 'family history strongly suggestive of a genetic etiology, including consanguinity' as a qualifying feature. The patient’s only documented family history is a mother with breast cancer at age 50, which the record does not document as 'strongly suggestive' per the policy; therefore the family-history criterion is not met.",Yes,"Policy requires pre- and post-test counseling by an appropriate provider (e.g., Certified Genetic Counselor). Patient has seen a genetic counselor multiple times, satisfying the counseling requirement described in the policy.",81415,"Policy examples list standard exome sequencing proband testing with CPT code 81415 (e.g., 'XomeDx - Proband' / Exome - Proband). The requested WES corresponds to 81415 per the policy.",No,"Per the policy, standard exome sequencing is medically necessary only when specific clinical criteria are met (multiple congenital anomalies OR developmental delay onset <18 OR TWO qualifying features) and the patient/family have been evaluated by a Board-Certified/Eligible Medical Geneticist or APGN. Although the patient had nondiagnostic CMA and has received genetic counseling, she only has a single congenital anomaly (choanal atresia), lacks a second qualifying clinical feature or multiple unrelated anomalies, and there is no documentation of evaluation by a Medical Geneticist/APGN. Therefore coverage criteria are not met.",12213,2930,15143
Case5885,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is requested; policy addresses genome sequencing (WGS/GS).,Yes,"Policy requires member <21 years of age for GS; patient is 11 years old, meeting the age criterion (policy: 'Member is <21 years of age').",Not Answerable,"Policy requires 'appropriate genetic and family history evaluation' and a clinical letter documenting the evaluation (differential, testing algorithm, prior tests/results) and ACMG-recommended pretest counseling by a geneticist/counselor. Patient info documents pre-test counseling discussed with a genetic specialist but does not state whether the required clinical letter/documentation or ordering/provider qualifications are provided, so insufficient information to determine compliance with ordering/provider documentation requirements.",No,"Policy defines specific clinical indications (e.g., epileptic encephalopathy, global developmental delay, multiple congenital abnormalities, OR TWO of a listed set including 'major abnormality affecting at minimum a single organ system'). The record documents a 'major abnormality affecting at least one organ system' but no second qualifying criterion is provided, so the patient does not meet the policy's specified medical-indication requirements.",Not Answerable,Policy requires that the member has not had prior exome or genome sequencing and requires documentation of prior tests in the clinical letter. Patient data lists prior Fragile X testing (nondiagnostic) but does not state prior exome/genome testing status or whether other recommended targeted tests/CMA/panels were performed; insufficient information to confirm required prior testing/documentation.,Not Specified,"Policy requires 'appropriate genetic and family history evaluation' but does not list family history (e.g., maternal long QT) as a standalone qualifying indication for routine GS in the general GS criteria (family history is explicitly listed in rWGS infant criteria). Thus family history is present (maternal long QT) but the policy does not specify that this family history alone meets GS eligibility.",Yes,"Policy/ACMG guidance requires pretest counseling by a medical geneticist or affiliated genetic counselor. Patient info states pre-test counseling was discussed with a genetic specialist and plans for post-test follow-up are in place, which meets the policy's counseling requirement (documentation of counseling was discussed though written consent/documentation is not explicitly stated).",81425,Policy lists CPT 81425 for proband whole-genome sequence analysis (policy: '81425 should be billed for the proband').,No,"Although age and pre-test counseling meet policy elements and 81425 is the correct CPT, the patient does not meet the policy's defined medical-indication criteria (only one qualifying feature documented, not the required criteria set), and there is insufficient evidence that the required clinical evaluation letter/testing algorithm/prior targeted testing documentation are provided. Per the guideline, these unmet documentation/clinical-criteria requirements make GS not medically necessary/approvable.",9147,3067,12214
Case14195,rag,all_incorrect,iter1,BRCA1/2,Patient was referred for BRCA1/2 testing (clinical info states BRCA1/2 testing is being ordered).,Not Specified,The provided policy (FEP 2.04.126) addresses CHEK2/ATM/BARD1 and references BRCA1/2 testing strategy in a different policy (2.04.02) but does not state age-based eligibility for BRCA1/2 in the supplied text.,Not Specified,The policy text discusses that genetic counseling should be performed by someone with expertise but does not specify ordering-provider (specialty) requirements for BRCA1/2 testing in the provided document.,Not Specified,The supplied policy references NCCN criteria and another policy (2.04.02) for BRCA1/2 testing indications but does not list explicit medical/clinical eligibility criteria for BRCA1/2 within this document.,Not Specified,The provided policy does not define specific required prior tests that must be completed before BRCA1/2 testing; it only notes testing an affected family member first has highest yield (no explicit prior-test requirement).,Not Specified,The policy discusses the importance of family history for breast/ovarian cancer risk but does not specify family-history criteria for BRCA1/2 in this document; the patient's reported family history (maternal uncle with dystonia/ataxia) is not described in the policy as relevant.,No,"The policy states genetic counseling should be performed by someone experienced when inherited-condition testing is considered; the patient has had no pretest genetic counseling, so counseling requirements in the policy are not met.",Not Specified,"The provided policy text does not list or reference CPT codes for BRCA1/2 or other genetic tests, so an appropriate CPT code cannot be determined from this document.",No,"Based on the provided policy material: (1) the document does not provide BRCA1/2 coverage criteria (refers to separate policy 2.04.02), (2) no documented personal or family history of breast/ovarian cancer is present in the patient facts to support medical necessity per referenced guideline approach, and (3) recommended pretest genetic counseling has not been done. Therefore coverage is not supported by the supplied policy text.",10991,2241,13232
Case2847,rag,all_incorrect,iter1,WES,Patient information explicitly states 'whole exome sequencing (WES) is being pursued.',Not Specified,The provided policy (FEP 2.04.59) does not specify age-based eligibility criteria for whole exome sequencing; WES is referenced as addressed in a separate policy (2.04.102) which is not provided.,Not Specified,The provided policy does not specify ordering-provider (specialty/type) requirements for WES; WES is addressed in a separate policy not included here.,Not Specified,"FEP 2.04.59 defines medical indications for CMA (developmental delay/ID, ASD, multiple congenital anomalies) and states NGS panels are investigational for those indications; it does not define clinical indications for WES in this document (WES is addressed separately).",Not Specified,"The policy does not define required prior testing specifically for WES. Although CMA is noted as first‑line for developmental delay/ID in this policy, no explicit prior-test requirement for WES is provided in the supplied text.",Not Specified,"The policy does not specify family history or consanguinity criteria that would determine eligibility for WES; the patient does have a maternal hematologic/immunologic disorder, but the policy contains no WES-specific family-history criteria.",Yes,"The policy states formal genetic counseling is recommended/expected for genetic testing and should be performed by an experienced individual; patient had pre-test counseling with a genetic counselor and plans for post-test follow-up, meeting the counselling expectation in the policy.",81415,The requested test is whole exome sequencing (WES); CPT code 81415 corresponds to exome sequencing (clinical exome sequencing).,No,"The provided policy (FEP 2.04.59) does not authorize WES for the described indication and states that next-generation sequencing panel testing is investigational for developmental delay/ID/ASD; WES is referenced as covered/ addressed only in a separate policy (2.04.102) not provided. There is no coverage criteria in this document supporting WES for this clinical scenario, so coverage is not supported based on the supplied policy.",15712,1965,17677
Case11855,rag,all_incorrect,iter1,CMA,Patient information states chromosomal microarray (CMA) is being ordered to assess for copy number variants; policy also addresses CMA testing (FEP 2.04.59).,Not Specified,The policy defines clinical indications for CMA but does not impose age-based eligibility limits for postnatal CMA; no age restriction is specified in the policy.,Not Specified,The policy discusses genetic counseling and testing settings but does not specify ordering-provider specialty or explicit provider-type requirements as a coverage condition for CMA.,No,"Policy statement: CMA is medically necessary as first-line for apparent nonsyndromic developmental delay/intellectual disability, autism spectrum disorder, or multiple congenital anomalies not specific to a well-delineated genetic syndrome. The patient has a congenital anomaly affecting a single organ system (not described as multiple anomalies) and no explicit statement of developmental delay/ASD in the provided information, so the patient does not meet the policy's listed medical indications.",Not Specified,"The policy does not state mandatory prior tests required universally before CMA; guidelines note fragile X and CMA are first-tier for ASD, but the policy does not make completion of specific prior tests a formal prerequisite for CMA coverage. (Patient did have Fragile X testing nondiagnostic.)",Not Specified,The policy does not define family history or consanguinity criteria as determinants for CMA eligibility; the patient's family history of a maternal aunt with breast cancer is not addressed as relevant in the CMA coverage criteria.,Not Specified,"The policy strongly recommends formal genetic counseling and states it should be performed by experienced personnel, but it does not state genetic counseling as an explicit coverage requirement. Patient did receive pre-test counseling with a genetic specialist and planned post-test follow-up.",Not Specified,"The policy document does not list or map CPT codes to chromosomal microarray testing, so no specific CPT code can be determined from the provided policy text.",No,"Based on FEP 2.04.59 coverage criteria, CMA is medically necessary for developmental delay/ID, ASD, or multiple congenital anomalies. The patient has a single-organ congenital anomaly without documentation of developmental delay/ASD, so the request does not meet the policy's specified medical indications for coverage.",15724,2354,18078
Case3465,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Not Specified,The UnitedHealthcare cardiac genetic testing policy does not specify age-based eligibility for whole genome sequencing (WGS); it gives pediatric age recommendations for targeted/predictive testing for specific cardiac genes but does not define age criteria for WGS.,Not Specified,The policy does not state specific ordering-provider/specialty requirements for WGS; it emphasizes pre-test genetic counseling but does not limit which provider may order the test.,Not Specified,"While the policy defines medical indications for multi-gene cardiac panels (including cascade testing for first-degree relatives of LQTS), it does not explicitly define clinical indications for WGS; therefore whether the patient meets an indication for the requested WGS is not specified in this policy.",Not Specified,"The policy does not list required prior tests that must be completed before WGS; prior cardiac-specific testing (e.g., ECG, exercise testing) is discussed for arrhythmia evaluation but no prior-test requirement for WGS is specified.",Yes,"Policy states multi-gene panel testing is medically necessary in asymptomatic individuals who have a first-degree relative with congenital LQTS; the patient has a father with Long QT syndrome (first-degree relative), so relevant family-history criteria (for cardiac panel testing) are met.",Yes,"Policy states pre-test genetic counseling is ""strongly recommended"" (and counseling is recommended for cardiomyopathy/arrhythmia testing); the patient completed pre-test counseling with a genetic counselor and has post-test counseling planned, meeting the counseling expectation in the policy.",Not Specified,"The policy's Applicable Codes list cardiac panel and related molecular codes (e.g., 81413, 81414, 81439) but does not list a CPT code for WGS among the provided options, so a matching CPT code for the requested WGS is not specified in this policy.",No,"The policy's coverage rationale addresses multi-gene panels and microarray testing for cardiac indications and explicitly defines when panels are medically necessary; it does not explicitly authorize whole genome sequencing (WGS) for this scenario. The requested WGS (ordered to evaluate developmental delay) is not specified as a covered cardiac genetic test in this policy, and the policy maps family-history coverage to targeted/multi-gene panels rather than WGS; therefore WGS is not covered per this policy.",39571,2713,42284
Case15557,rag,all_incorrect,iter1,WGS,Patient information explicitly states testing is being pursued with whole genome sequencing (WGS).,Yes,Policy eligibility is written for 'children' with unexplained congenital or neurodevelopmental disorders; the patient is 15 years old and therefore meets the pediatric (child) age context in the policy.,No,The policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics (Policy Statement #1). The record only notes referral by neurology and multiple genetic counseling visits; there is no explicit documentation that a clinician with expertise in clinical genetics evaluated the patient.,Yes,"Policy medical indications include children with unexplained congenital anomalies after prior genetic testing or when genetic etiology is most likely. The patient has a congenital anomaly since birth, prior genetic testing (FISH) was nondiagnostic, and a sibling with a similar anomaly, consistent with the policy's defined clinical indication.",Yes,"The policy language expects prior genetic testing (e.g., CMA or targeted testing) or prior testing failing to yield a diagnosis. The patient had prior FISH testing that was nondiagnostic, satisfying the policy requirement that previous genetic testing failed to yield a diagnosis.",Yes,"The policy notes family history (eg, developmental delay or genetic disease) as relevant. The patient has a sibling with a similar congenital anomaly, constituting a relevant family history per the policy.",Yes,"The policy requires genetic counseling by an individual with experience in genetic medicine. The patient has been seen by a genetic counselor multiple times and plans for post-test counseling, meeting the policy's genetic counseling requirement.",Not Specified,The provided policy document does not specify corresponding CPT code(s) for WGS; no CPT mappings are given in the policy text excerpt.,No,"Although the patient meets clinical indications (unexplained congenital anomaly, prior nondiagnostic genetic testing, relevant family history, and genetic counseling), the policy requires documentation of evaluation by a clinician with expertise in clinical genetics as part of the ALL criteria for medical necessity. That documentation is not present in the patient information; therefore, per the policy's ordering/provider requirement, the test is not covered.",14831,3228,18059
Case4982,rag,all_incorrect,iter1,WES,Patient is being considered for whole exome sequencing (WES) per the clinical information (explicit statement).,Yes,Policy applies to 'children' with unexplained congenital or neurodevelopmental disorders; the patient is 11 years old and therefore meets the age-related application (also consistent with ACMG guidance referenced in policy for onset prior to 18 years).,No,"Policy criterion 1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The record documents referral by a developmental pediatrician and genetic counseling visits, but does not document evaluation by a clinician with expertise in clinical genetics, so ordering/provider requirement is not met per policy.",Yes,"Policy permits WES for children with unexplained congenital or neurodevelopmental disorders when criteria met. The patient has Hirschsprung disease (listed in policy examples as highly suggestive of genetic etiology), prior nondiagnostic genetic testing, and a sibling with early-onset epileptic encephalopathy, supporting a suspected genetic etiology.",No,"Policy criterion 3 references previous genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or prior testing that failed to yield a diagnosis. The patient has only prior nondiagnostic FISH documented; no CMA or targeted testing is documented, so required prior testing per policy is not clearly completed.",Yes,"Policy lists family history of developmental delay/epilepsy as relevant. The patient has a sibling with epileptic encephalopathy before age 3, which is relevant family history per the policy.",Yes,"Policy requires genetic counseling; the family has met with a genetic counselor multiple times for pre-test counseling and plans post-test disclosure, satisfying the counseling requirement.",81415,The requested test is whole exome sequencing (WES); the CPT code among options that corresponds to exome sequencing is 81415.,No,"Policy requires ALL stated criteria be met. Although age, medical indication, family history, and counseling are present, documentation is lacking that the patient was evaluated by a clinician with expertise in clinical genetics and required prior testing (eg, CMA/targeted testing) is not documented. Because criterion 1 (genetics clinician evaluation) and prior testing requirements are not clearly met in the provided clinical information, the request does not meet the policy's ALL criteria for coverage.",14860,2632,17492
Case14371,rag,all_incorrect,iter1,WES,Patient information explicitly states the general pediatrician ordered whole exome sequencing (WES).,Yes,Policy requires member <21 years for ES; the patient is 11 years old and therefore meets the age criterion (MOL.TS.235.C).,Not Specified,The policy requires an appropriate genetic and family history evaluation and a clinical letter but does not specify a required ordering provider specialty or type for ordering ES.,Yes,"Policy allows ES when TWO of listed criteria are met (e.g., formal diagnosis of autism AND symptoms of a complex neurodevelopmental disorder). The patient has a formal autism diagnosis and a complex neurodevelopmental disorder, meeting the medical indication portion of the policy.",Yes,The policy explicitly requires that the member has not had prior ES or genome sequencing; patient has no prior ES/WGS documented and prior Fragile X testing was nondiagnostic (prior testing documented).,Not Specified,"While the policy requires a family history evaluation be performed and documented, it does not establish specific family-history or consanguinity criteria as standalone eligibility requirements for ES; patient does have a relevant family history but the policy does not use this as an isolated approval criterion.",Yes,"Policy/ACMG guidance requires pretest counseling by a genetic professional and documentation; the patient met with a genetic counselor before testing with plans for post-test follow-up, satisfying the counseling requirement.",81415,Billing section states 81415 should be billed for the proband when analyzing the entire exome sequence; this is the appropriate CPT for proband WES per policy.,No,"Although age, medical indication (autism + complex NDD), absence of prior ES/WGS, and pretest genetic counseling are met, the policy requires an accompanying clinical letter documenting differential diagnoses, testing algorithm, prior tests/results, statement that a genetic etiology is most likely, recommendation that ES is most appropriate, and predicted impact on care. The provided patient information does not document that this required clinical letter and other required documentation (e.g., that alternate etiologies were considered/ruled out or that first-tier testing is not appropriate) have been submitted, so coverage criteria are not fully met per the policy.",10483,3180,13663
Case15202,rag,all_incorrect,iter1,BRCA1/2,Patient was referred for BRCA1 and BRCA2 testing (stated in the patient information).,Not Specified,The provided policy (FEP 2.04.126) does not specify age-based eligibility criteria for BRCA1/2 testing; it references a separate review (2.04.02) for BRCA testing but no age limits are given in this document.,Not Specified,The policy emphasizes genetic counseling by an experienced provider but does not specify ordering-provider specialty or other formal ordering requirements for BRCA1/2 testing in the provided text.,Yes,"Within the policy text, the American Society of Breast Surgeons guideline (included in this document) states genetic testing should be made available to all individuals with a personal history of breast cancer and should include BRCA1/2; the patient has a personal history of a malignant breast tumor (malignant phyllodes), meeting that clinical indication per the guideline in the policy.",Not Specified,"The provided policy does not define required prior tests that must be completed before BRCA1/2 testing (it notes testing an affected family member first has highest yield, but does not mandate prior tests).",Not Specified,The policy discusses family history as relevant to risk assessment generally (and to inclusion of genes on panels) but does not provide explicit family-history/consanguinity criteria for BRCA1/2 in this document; the patient's reported sister's immunologic/hematologic disorder is not identified in the policy as relevant to BRCA testing.,Yes,"The policy recommends formal genetic counseling performed by an experienced provider. The patient completed pre-test counseling with a genetic specialist and has plans for post-test follow-up, satisfying the counseling expectation described in the policy.",Not Specified,The provided policy text does not list or map specific CPT codes to BRCA1/2 testing; no CPT coding guidance is given in this document.,Yes,"The policy (via included guideline excerpts) supports BRCA1/2 testing for individuals with a personal history of breast cancer and states BRCA1/2 should be included for such patients; benefits are available for specialized diagnostic genetic testing when medically necessary. The patient has a personal history of a malignant breast tumor and pre-test genetic counseling, so under the policy's guideline-based criteria the BRCA1/2 test would be covered.",11021,2768,13789
Case8621,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being performed.,Yes,"Policy applies to children with unexplained neurodevelopmental disorders; the patient is a 2-year-old child, meeting the age-based (pediatric/children) applicability in the policy.",No,"Policy criterion 1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The ordering provider is documented as the child’s oncologist and there is no documentation provided that a clinician with expertise in clinical genetics evaluated the child, so the provider requirement is not met per the provided facts.",Yes,"Policy permits WES for children with unexplained neurodevelopmental disorders after standard workup; the patient has a complex neurodevelopmental disorder with autism and prior CMA was nondiagnostic, meeting the medical indication.",Yes,"Policy allows WES when previous genetic testing (eg, chromosomal microarray) failed to yield a diagnosis; the family reports prior CMA testing was nondiagnostic, so required prior testing has been completed.",Yes,"Policy guidance lists family history (eg, congenital anomalies or developmental delay) as relevant; the family reports an uncle with a congenital anomaly, which is a relevant family history per the policy.",Yes,"Policy states genetic counseling should be performed by someone with expertise; the family reports multiple meetings with a genetic counselor with pre-test counseling completed and planned post-test follow-up, satisfying the counseling requirement in the record.",81415,"The requested test is whole exome sequencing (WES); among the listed CPT options, 81415 corresponds to exome sequencing and therefore best matches the requested test.",No,"Policy requires ALL listed criteria be met for WES to be medically necessary. Although the patient meets age, medical indication, prior testing (CMA nondiagnostic), family history, and genetic counseling criteria, there is no documentation that the child was evaluated by a clinician with expertise in clinical genetics (policy criterion 1). Because that required criterion is not met in the provided information, the request does not satisfy ALL policy requirements and is not covered per the policy.",14841,1942,16783
Case14141,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is planned.,Yes,"Policy specifies WES may be medically necessary for evaluation of unexplained congenital/neurodevelopmental disorders in children; the patient is a 7-year-old child, satisfying the 'children' age criterion.",No,"The policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The order is from an oncologist and the record does not state evaluation by a clinician with expertise in clinical genetics, so ordering-provider requirement is not documented.",Yes,"Policy medical indications include unexplained multiple congenital anomalies and prior nondiagnostic genetic testing (e.g., CMA). The patient has multiple congenital anomalies and a nondiagnostic CMA, matching the clinical indication.",Yes,"Policy expects prior standard genetic testing (e.g., CMA) to be nondiagnostic before WES; the patient had CMA reported as nondiagnostic.",Yes,"Policy lists family history (e.g., developmental delay) as relevant; the patient has a sibling with global developmental delay, which is relevant to eligibility.",Yes,Policy requires documentation of individualized genetic counseling before testing. Patient information states pre-test genetic counseling was completed with arrangements for post-test counseling.,81415,"CPT 81415 is the code listed in the policy for exome sequence analysis (WES), which corresponds to the requested test.",No,"Under the policy all listed criteria must be met for WES to be medically necessary. Although age, clinical indication, prior CMA, family history, and pre-test counseling are met, the policy requires evaluation by a clinician with expertise in clinical genetics (ordering/provider requirement) and that documentation is not present (ordering provider is an oncologist). Therefore not all policy criteria are met and the test is not covered per the policy.",56577,2139,58716
Case6747,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) was ordered by the medical geneticist.,Not Specified,The provided FEP 2.04.59 policy does not state any age-based eligibility limits for whole genome sequencing; age criteria are not specified in this document.,Not Specified,The policy does not specify ordering-provider (specialty or provider-type) requirements for WGS; it only generally recommends genetic counseling by an experienced individual.,Not Specified,The policy describes indications and coverage for chromosomal microarray and states NGS gene panels are investigational; it does not provide coverage or clinical criteria specific to WGS (WES/WGS are addressed in a separate policy not provided).,Not Specified,"The policy designates CMA as first-line for the listed indications and notes additional testing may follow, but it does not define mandatory prior-test requirements for WGS specifically in this document.",Not Specified,"While the patient has a sibling with developmental delay, the provided policy does not specify family-history or consanguinity criteria that would determine eligibility for WGS in this document.",Yes,"The policy states formal genetic counseling is recommended/appropriate when genetic testing is considered and should be performed by someone experienced; the patient completed pre-test counseling and post-test counseling is planned, which meets the policy's counseling expectation.",Not Specified,The FEP 2.04.59 policy text provided does not list or map CPT codes to whole genome sequencing; no CPT code is specified in this document for WGS.,No,"The provided policy does not authorize coverage for WGS: WES/WGS are noted as addressed in a different policy (2.04.102) not included here, next-generation sequencing panels are stated investigational, and the Benefit Application excludes experimental/investigational procedures. Therefore, based solely on this document, WGS is not covered.",15679,2095,17774
Case811,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued.,Not Specified,The provided FEP 2.04.59 policy does not state any explicit age-based eligibility limits for WES; it generally addresses children/postnatal testing but gives no age criteria for WES.,Not Specified,The policy discusses genetic counseling and specialists for interpretation but does not specify explicit ordering-provider specialty or credential requirements for WES.,Not Specified,FEP 2.04.59 defines clinical indications for CMA and states NGS panels are investigational; WES is referenced as addressed in a separate policy (2.04.102) and this document does not provide explicit medical-necessity criteria for WES.,Not Specified,"The policy notes CMA is first-line for developmental delay/ congenital anomalies and guidelines mention further testing (including WES) when initial testing is nondiagnostic, but the policy does not state a required prior-test sequence as a formal coverage prerequisite for WES in this document.",Not Specified,"The policy does not set specific family-history or consanguinity criteria for WES; although the patient has a positive sibling history, the document does not define this as an explicit criterion for WES coverage.",Not Specified,"The policy strongly recommends formal genetic counseling and states it should be performed by experienced personnel, but it does not define genetic counseling as an explicit, stated coverage requirement for WES within this policy.",Not Specified,The FEP 2.04.59 policy text does not reference or map specific CPT codes to WES; no CPT guidance is provided in the supplied document.,No,"Under FEP 2.04.59, whole-exome sequencing is not addressed in this policy (it is referred to a separate policy 2.04.102). The document states next-generation sequencing panel testing is considered investigational for these indications and that experimental/investigational procedures are not covered. Because WES coverage criteria are not provided in this policy and NGS testing is labeled investigational here, the requested WES is not covered per the provided policy text.",15731,2465,18196
Case7604,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Yes,"Policy covers WES/WGS for children/infants with unexplained congenital anomalies. The patient is a neonate with multiple congenital anomalies, which fits the policy's child/infant age group.",No,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled. The record indicates referral and ordering by a neurologist and no genetics evaluation is documented, so ordering provider requirements are not met per policy.",Yes,"Policy lists multiple congenital anomalies as a medical indication for WES/WGS. The neonate has multiple congenital anomalies affecting several organ systems, meeting that clinical criterion.",Yes,"Policy allows WES/WGS when previous genetic testing has failed to yield a diagnosis. The patient had prior FISH testing that was nondiagnostic, satisfying the 'previous testing failed' criterion.",Yes,"Policy identifies relevant family history (eg, affected sibling, developmental delay/genetic disease) as supportive. The patient has an older sibling with multiple congenital anomalies, which is relevant per policy.",No,"Policy requires counseling by an experienced genetics provider prior to testing. The family declined genetic counseling, so the policy's counseling requirement is not met.",Not Specified,The provided policy document does not list or map CPT codes to WGS/WES; no CPT code for WGS is specified in the text.,No,"Although the patient meets clinical indications (multiple congenital anomalies), the policy requires ALL criteria including evaluation by a clinician with expertise in clinical genetics and counseling. Those documentation/counseling requirements are not met (family declined counseling and no genetics evaluation documented), so coverage criteria are not fully satisfied.",14826,2573,17399
Case950,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued to look for an underlying genetic cause.,Not Specified,The policy does not set explicit age cutoffs for WES; it discusses age of seizure onset as a factor (early-onset DEE) but does not impose an age-based eligibility limit for testing.,Not Specified,The guideline requires the rendering laboratory be a qualified provider per plan policy but does not specify ordering-provider specialty or type requirements for WES.,Yes,"Policy lists testing as medically necessary for early-onset epileptic encephalopathy/DEE; the patient has unexplained epileptic encephalopathy with onset before age 3 and no known cause, meeting the clinical indication.",Not Specified,The guideline does not require specific prior tests prior to WES/multi-gene testing in this scenario; patient had nondiagnostic karyotype and no prior epilepsy multigene panel (which the policy notes would preclude repeat testing).,No,"The policy includes family-history criteria for some epilepsy testing (e.g., focal epilepsy with positive family history), but the patient's family history (an uncle with prostate cancer) is not a relevant family history for monogenic epilepsy.",Not Specified,"While the guideline cites professional recommendations supporting genetic counseling, it does not state a formal counseling requirement as a coverage criterion; patient does have counseling documented.",81415,WES corresponds to exome sequencing CPT code 81415; patient is requesting whole exome sequencing.,Yes,"Under the policy, testing is medically necessary for early-onset epileptic encephalopathy/DEE and the patient has unexplained early-onset epileptic encephalopathy (onset <3 years), has no prior epilepsy multigene panel, and karyotype was nondiagnostic; these facts meet the coverage criteria.",12786,1956,14742
Case17822,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered as the next-tier diagnostic test after a nondiagnostic CMA.,Yes,Policy medical-necessity criteria apply to 'children' with unexplained congenital anomalies; the patient is 13 years old and therefore meets the age-based (pediatric) scope of the policy.,Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics; the order was placed by a medical geneticist, satisfying the ordering-provider requirement in the policy (criterion 1).",No,"The policy defines medical indications for rapid WGS/WES in critically ill infants and for standard WES in children with unexplained congenital anomalies after prior testing. The patient is not critically ill and requested non-rapid WGS; the policy states 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations,' so the patient does not meet a defined medical indication for WGS under this policy.",Not Specified,"The policy specifies prior testing requirements (eg, CMA) for medically necessary WES, but it does not define specific required prior testing for non-rapid WGS in non-critically ill children. (Note: the patient did have a nondiagnostic CMA.)",No,"The policy lists specific family-history items relevant to eligibility (eg, developmental delay, BRUE in sibling). The patient's family history (a sibling with short stature) is not among the specified relevant family-history criteria.",No,"Policy criterion 1 requires the individual be counseled about risks of genetic testing by a clinician with genetics expertise. The patient declined genetic counseling prior to testing, so counseling requirements were not met.",81425,The requested test is whole genome sequencing; CPT code 81425 corresponds to whole genome sequencing and is the best match for the ordered test.,No,"Per the policy, non-rapid WGS in non-critically ill children is considered investigational ('Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations'). The patient is a non-critically ill 13-year-old; additionally pre-test genetic counseling (required by the policy) was declined. Therefore WGS is not covered under this policy.",14838,2673,17511
Case9408,rag,all_incorrect,iter1,WES,Patient information states the 17-year-old is undergoing whole exome sequencing (WES) requested by a medical geneticist.,Yes,"Policy applies to infantile- and early-childhood-onset epileptic encephalopathies with onset before age 5; patient had seizure onset before age 3, meeting the age-related criterion (policy: 'Onset of seizures in early childhood (ie, before the age of 5 years)').",Not Specified,The policy does not specify required ordering-provider specialty or credentials for genetic testing; patient’s ordering provider is a medical geneticist but no provider-specific requirement is listed in this policy.,Yes,"Policy medical-necessity criteria apply to early-childhood epileptic encephalopathies (onset <5 years, severe seizures/EEG abnormalities, no other syndrome better explaining symptoms). Patient has epileptic encephalopathy with onset before age 3, meeting the policy's clinical indication for testing.",Not Specified,"The policy discusses testing strategies (targeted gene testing, panels, and references WES criteria in a related policy) but does not mandate specific prior tests be completed before WES; patient did have a nondiagnostic CMA but the policy does not require CMA prior to WES.",Not Specified,"The policy does not define family history or consanguinity criteria affecting eligibility for epilepsy genetic testing; although patient has a maternal history of an immunologic/hematologic disorder, the policy does not make this an eligibility criterion.",Yes,"Policy states experts recommend formal genetic counseling and that counseling should be performed by experienced personnel; patient completed pre-test counseling and plans post-test follow-up with a genetic counselor, satisfying the policy's counseling expectations.",81415,The requested test is whole exome sequencing (WES); CPT code 81415 corresponds to exome sequencing (per coding options provided).,Yes,"Under the FEP policy, genetic testing for infantile-/early-childhood-onset epileptic encephalopathies may be considered medically necessary when criteria are met. The patient has onset <5 years (before age 3), a clinical diagnosis of epileptic encephalopathy, prior nondiagnostic CMA, testing ordered by a genetics specialist, and genetic counseling performed — collectively meeting the policy's medical-necessity application.",15092,2112,17204
Case3592,rag,all_incorrect,iter1,CMA,Patient information explicitly states 'chromosomal microarray (CMA) testing ... is being requested.' Basis: patient clinical info.,Not Specified,"The Cigna epilepsy guideline defines clinical diagnoses (eg, early infantile epileptic encephalopathy, neonatal seizures) but does not state an explicit age cutoff requirement for CMA; age-based eligibility criteria are not specified for CMA in the policy.",Not Specified,The policy requires the rendering laboratory be qualified but does not specify ordering-provider specialty or other provider requirements for CMA; no explicit ordering-provider criteria for this test are provided.,Not Specified,"The guideline specifies medical necessity criteria for epilepsy single-gene tests and multigene panels (eg, early infantile epileptic encephalopathy) but does not provide explicit coverage/medical-necessity criteria specific to CMA; although the patient meets diagnostic features (neonatal epileptic encephalopathy), CMA-specific indications are not defined in the policy.",Not Specified,"The policy does not list required prior tests before performing CMA. Although the patient had a prior nondiagnostic CMA, the guideline does not specify prior-testing prerequisites for CMA.",No,"The guideline does list family history as a specific criterion for some epilepsy panel indications (eg, focal epilepsy with positive family history suggestive of monogenic inheritance). The patient’s family history is an older sibling with unexplained developmental regression (not described as epilepsy or a family history suggestive of monogenic epilepsy), so it does not meet the family-history criterion as specified in the policy.",Not Specified,"Although the patient notes pre-test counseling occurred, the Cigna guideline does not list genetic counseling as an explicit coverage requirement for CMA; counseling is recommended by professional groups but is not defined as a coverage prerequisite in the policy.",Not Specified,"The policy lists many CPT codes for epilepsy gene tests and discusses CGH/CMA conceptually, but it does not provide a specific CPT code for chromosomal microarray within the document. None of the provided answer choices are explicitly linked to CMA in the policy text.",No,"The requested test is CMA, but the Cigna epilepsy guideline's coverage criteria focus on single-gene testing, multigene panels, ES/GS and do not define CMA-specific medical-necessity criteria. Additionally the patient already had a prior nondiagnostic CMA. Based strictly on the policy text (no explicit CMA coverage criteria and emphasis on panels/ES/GS for neonatal epileptic encephalopathy), the requested repeat CMA is not supported as meeting explicit coverage criteria.",12764,2735,15499
Case17929,rag,all_incorrect,iter1,CMA,Patient info explicitly states 'tumor chromosomal microarray (CMA) testing has been requested' after nondiagnostic karyotype; policy addresses CMA testing.,Not Specified,The policy addresses postnatal CMA in children but does not state specific numeric age limits; patient is 7 years old but no age-based eligibility criteria are specified in the policy.,Not Specified,The policy does not define specific ordering-provider specialty or credential requirements for CMA; patient was referred by a neurologist but the policy contains no ordering-provider requirement.,No,"Policy lists medical indications for CMA as (1) nonsyndromic developmental delay/intellectual disability, (2) autism spectrum disorder, or (3) multiple congenital anomalies not specific to a well-delineated genetic syndrome. The provided clinical information documents a major abnormality affecting at least one organ system but does not document developmental delay/ASD or multiple congenital anomalies, so the patient does not clearly meet the policy's specified indications.",Not Specified,"The policy permits CMA as a first-line test and does not require completion of specific prior tests before CMA; although the patient had prior karyotype testing, the policy does not mandate prior testing.",Not Specified,"The policy does not list family history or consanguinity as coverage criteria for CMA. The patient has a maternal BRCA1/2 pathogenic variant in relatives, but the policy does not make family history of unrelated hereditary cancer genes relevant to CMA eligibility.",Not Specified,"The policy strongly recommends genetic counseling and states it should be performed by an experienced provider, but it does not state formal genetic counseling as an explicit required condition for CMA coverage. The patient has had multiple pretest counseling sessions, which aligns with the policy's recommendation.",Not Specified,The policy document does not specify CPT or billing codes for CMA; none of the provided CPT options are referenced in the policy text.,No,"Coverage is limited to the policy-defined indications (nonsyndromic developmental delay/ID, ASD, or multiple congenital anomalies). The patient's record does not document developmental delay/ASD or multiple congenital anomalies per the policy definitions, so under the policy the requested CMA is not supported as meeting the specified medical necessity criteria.",15707,2035,17742
Case12834,rag,all_incorrect,iter1,CMA,Patient record states chromosomal microarray (CMA) testing has been ordered. (Patient fact),Yes,Policy addresses CMA as first-line testing in infants/children and postnatal evaluation for developmental delay/ID; the patient is a 16‑year‑old (pediatric/postnatal) and therefore meets the age context in the policy. (Policy: CMA may be considered medically necessary as first-line in children; Patient fact: age 16),Not Specified,The policy discusses genetic counseling and follow-up but does not specify prescriptive ordering‑provider specialty or credential requirements for ordering CMA. (Policy: no explicit ordering provider requirement),Yes,"Policy lists apparent nonsyndromic developmental delay/intellectual disability, ASD, or multiple congenital anomalies as indications for CMA; the patient was referred by a developmental pediatrician for a complex neurodevelopmental disorder (developmental indication) and prior Fragile X was nondiagnostic, matching the policy indications. (Policy indication + Patient facts)",Not Specified,"The policy does not mandate completion of specific prior tests before CMA (it notes fragile X and CMA are first‑tier tests), so there is no required prior testing sequence specified as a condition of coverage. (Policy: stepwise approach mentions fragile X and CMA as first tier; no prerequisite requirement)",Not Specified,"The policy does not use family history or consanguinity as a required eligibility criterion for CMA; although the patient has a maternal uncle with a movement disorder, the policy does not tie eligibility to that family history. (Policy: eligibility based on patient phenotype; Patient fact: family history present but policy does not make it a criterion)",Not Specified,"The policy recommends formal genetic counseling and states it should be performed by someone experienced, but it does not state counseling is a mandatory coverage requirement or precondition for CMA. The record shows counseling is not documented but the policy does not define counseling as required for coverage. (Policy: counseling recommended; Patient fact: not documented)",Not Specified,The policy document does not provide or map specific CPT codes to CMA or other tests; therefore a specific CPT code cannot be identified from the provided policy text. (Policy: no CPT code listing),Yes,"Per the policy, chromosomal microarray may be considered medically necessary as first‑line testing for individuals with apparently nonsyndromic developmental delay/intellectual disability or related neurodevelopmental disorders. The 16‑year‑old patient has a complex neurodevelopmental disorder, was referred for evaluation, and prior Fragile X testing was nondiagnostic, so CMA is covered under the policy. (Policy statement + Patient facts)",15704,2567,18271
Case4604,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being requested to evaluate an underlying genetic cause.,Not Specified,The provided FEP 2.04.59 policy does not define age-based eligibility limits for WES; it addresses postnatal CMA as first-line but does not specify age criteria for WES.,Not Specified,The policy discusses genetic counseling and that testing should be ordered in the clinical genetics context but does not specify explicit ordering-provider (specialty/type) requirements for WES.,Not Specified,"FEP 2.04.59 defines medical indications for CMA (apparently nonsyndromic developmental delay/ID, ASD, multiple congenital anomalies) and states NGS panels are investigational; it does not define specific medical-indication criteria for WES within this policy (WES is addressed in a separate policy).",Not Specified,"The policy describes a stepwise approach (first-tier fragile X and CMA) in guidelines but does not state an explicit required prior-test completion rule for WES in this document. The patient did have nondiagnostic CMA, but the policy does not mandate specific prior testing for WES here.",Not Specified,"The policy does not set family-history or consanguinity criteria specific to WES; although family history is noted in the patient record (affected sibling), the policy does not define family-history–based eligibility for WES in this document.",Not Specified,"The policy recommends genetic counseling generally and that it should be performed by experienced individuals, but it does not state an explicit coverage precondition or formal counseling requirement specific to WES in this policy. The patient did complete pre-test counseling.",81415,"The test requested is whole exome sequencing (WES); among the provided CPT options, 81415 corresponds to exome sequence analysis/interpretation and is the best match for WES.",No,"Under FEP 2.04.59, chromosomal microarray is the medically necessary first-line test for nonsyndromic developmental delay/ID; the policy states next-generation sequencing panels are considered investigational in all such cases and WES is not authorized by this policy (it is addressed separately). Based solely on this provided policy, WES is not supported/covered here.",15708,2047,17755
Case8661,rag,all_incorrect,iter1,WGS,Patient case explicitly states 'whole genome sequencing (WGS) is requested to investigate a possible genetic cause.',Yes,Policy eligibility is defined for 'children' with unexplained congenital or neurodevelopmental disorders; the patient is 7 years old (a child) and thus meets the age-related designation in the policy.,No,"Policy requires 'documentation that the individual has been evaluated by a clinician with expertise in clinical genetics ... and counseled.' The ordering/referring provider is the child's neurologist and there is no documentation that a clinician with expertise in clinical genetics evaluated the patient, so the provider requirement is not met.",No,"Policy requires ALL criteria for medical necessity (genetics evaluation and counseling, potential for change in management, and prior appropriate genetic testing or failed testing). The record lacks documentation of evaluation by a genetics clinician/counseling and does not document prior standard testing (eg, CMA and/or targeted single‑gene testing) beyond nondiagnostic Fragile X, so the required medical-indication criteria are not met.",No,"Policy specifies prior genetic testing (eg, chromosomal microarray and/or targeted single-gene testing) or failed prior testing as part of criteria. Only nondiagnostic Fragile X testing is documented; CMA/targeted testing or an otherwise adequate standard workup is not documented, so required prior testing has not been completed.",Yes,"Policy guidelines list relevant family history examples (eg, developmental delay, inborn error, early severe neurologic disease). The patient has a sibling with early-onset epileptic encephalopathy, which is a relevant family history per the policy.",No,"Policy requires the individual be '...evaluated by a clinician with expertise in clinical genetics, including at minimum ... and counseled about the potential risks of genetic testing.' Pre-test genetic counseling was offered but declined; thus the policy's counseling requirement is not met.",Not Specified,The provided policy document does not list or specify CPT codes for WGS; therefore a specific CPT code cannot be determined from the policy text.,No,"Coverage (medical necessity) for WGS requires ALL policy criteria (including evaluation by a genetics clinician with counseling and prior appropriate testing) for children with unexplained congenital or neurodevelopmental disorders. The record lacks documentation of genetics evaluation/counseling and prior standard genetic testing (eg, CMA or targeted testing), so the policy criteria are not met and the test is not covered per the policy.",14854,2017,16871
Case6451,rag,all_incorrect,iter1,WGS,The patient information explicitly states whole genome sequencing (WGS) is being pursued.,Yes,"The patient is a 7-week-old infant; the policy describes eligibility categories for infants/children (e.g., rapid WGS/WES for infants) so the patient's age falls within the infant/child category described in the policy.",Not Answerable,"The policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The record states evaluation by a developmental pediatrician and that pre-test counseling was completed, but it does not explicitly document evaluation by a clinician with expertise in clinical genetics, so adequacy cannot be determined from provided information.",Yes,"The policy lists 'significant hypotonia' as a clinical feature suggesting a genetic disease and an indication for sequencing; the infant has significant hypotonia and a suspected genetic cause, meeting a medical indication in the policy.",No,"The policy's standard WES/WGS criteria expect prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or prior testing that failed to yield a diagnosis. The patient had a prior karyotype (nondiagnostic), but no documentation of CMA or targeted single-gene testing, so required prior testing per policy is not completed.",No,"The policy specifies relevant family history examples (developmental delay, inborn error of metabolism, BRUE, arrhythmia/LQTS, sudden unexplained death). The maternal history of a severe immunologic/hematologic disorder is not among the family-history items the policy cites as relevant to sequencing eligibility.",Yes,"The policy requires genetic counseling by an experienced individual; the patient record indicates pre-test counseling has been completed and post-test genetics follow-up is planned, satisfying the counseling requirement per the policy.",Not Specified,"The provided policy document does not list or map specific CPT codes to WES/WGS, so a specific CPT code cannot be determined from the policy text alone.",No,"Per the policy, whole genome sequencing is considered investigational for diagnosis of genetic disorders in all other situations except rapid WGS for critically ill infants in NICU/PICU. This infant is not documented as critically ill or in NICU, prior recommended genetic testing (eg, CMA) is not documented, and evaluation by a genetics clinician is not documented; therefore WGS is not covered under the policy.",14828,3535,18363
Case19255,rag,all_incorrect,iter1,BRCA1/2,Patient referred for BRCA1/2 testing to evaluate hereditary breast/ovarian cancer; policy is the BRCA Analysis guideline (addresses BRCA1/2 testing).,Yes,"Policy age requirement for BRCA analyses is ≥18 years for full sequence/known familial/founder testing; patient is 38, which meets the ≥18 requirement.",Not Specified,"The policy requires pre- and post-test genetic counseling by an appropriate provider and that the rendering laboratory be qualified, but does not specify a required ordering provider specialty or restrict which clinician may order testing.",Yes,"Policy Full Sequence Analysis diagnostic criteria include 'diagnosed with two or more primary breast cancers at any age'; patient has two separate primary breast cancers, meeting this medical indication.",Not Specified,The policy does not mandate any specific prior test that must be completed before full BRCA sequencing for this scenario (requirements are mainly absence of prior full sequencing); patient has no prior BRCA sequencing reported.,Yes,"Family history is addressed in the policy and is relevant; patient reports a first-degree relative (father) with metastatic prostate cancer, which is a listed related family history in the guideline.",Yes,"Policy requires pre- and post-test genetic counseling by an appropriate provider; patient completed pre-test counseling with a genetic specialist, satisfying the pre-test counseling requirement noted in the policy.",81162,"Policy lists CPT options and states when sequencing and deletion/duplication analysis are performed concurrently, CPT 81162 (BRCA1/2 full sequencing and duplication/deletion analysis combined) is likely most appropriate; patient meets criteria for full sequencing and deletion/duplication.",Yes,"Based on policy: patient is ≥18, completed pre-test genetic counseling, meets medical criteria (two primary breast cancers) and has relevant family history (father with metastatic prostate cancer); therefore BRCA1/2 testing meets the guideline criteria for coverage.",10259,2099,12358
Case2211,rag,all_incorrect,iter1,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing per the clinical information; policy addresses BRCA1/BRCA2 testing.,Yes,"Policy specifies testing in minors is investigational; the patient is age 21 (an adult), so age-based restriction for minors does not apply and age is acceptable.",Not Specified,"Policy requires testing be performed in a setting with suitably trained providers and access to a CLIA lab and recommends genetic counseling, but it does not mandate a specific ordering provider specialty; the chart shows pre-test counseling by a genetic specialist but the policy does not specify precise ordering-provider credentials.",Yes,Policy states testing is medically necessary for individuals with any close blood relative with a known BRCA1/BRCA2/PALB2 pathogenic variant; the patient reports the mother carries a known BRCA2 pathogenic variant.,Not Specified,"Policy recommends targeted testing when a familial BRCA variant is known and testing affected relatives first when appropriate, but it does not require completion of other prior tests before testing this patient; no mandatory prior test completion is specified.",Yes,Policy includes family history criteria and the patient has a relevant family history: a mother with a known BRCA2 pathogenic variant and at least two additional affected blood relatives on the same side.,Yes,"Policy requires testing be performed in a setting able to provide pre- and post-test counseling and recommends formal genetic counseling; the patient completed pre-test counseling with a genetic specialist and plans post-test follow-up, meeting counseling expectations.",Not Specified,"The provided policy document does not list or specify CPT codes for BRCA1/BRCA2 testing, so a specific CPT code cannot be determined from the policy text.",Yes,"Per policy, testing is medically necessary for individuals with any close blood relative with a known BRCA pathogenic/likely pathogenic variant; patient’s mother has a known BRCA2 pathogenic variant and counseling was completed, satisfying policy criteria for coverage.",18964,2302,21266
Case18882,rag,all_incorrect,iter1,WES,Patient information states whole exome sequencing (WES) is being requested.,Not Specified,Policy refers to 'children' but does not specify numeric age cutoffs for WES eligibility; no explicit age-based exclusion/inclusion is given for an 8-year-old.,No,"Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics and counseling about risks prior to testing. The ordering/referring provider is a developmental pediatrician and the record does not document evaluation by a clinical genetics expert, so the provider requirement is not met per policy.",Yes,"Policy states WES is medically necessary for children with unexplained multiple congenital anomalies; the patient is an 8-year-old with multiple congenital anomalies affecting several organ systems, meeting the clinical indication.",Yes,"Policy requires previous genetic testing failed to yield a diagnosis (eg, CMA or targeted testing) or that a genetic etiology is likely despite prior testing. The patient had prior FISH testing that was nondiagnostic, satisfying the 'previous genetic testing failed to yield a diagnosis' criterion in the policy.",Yes,"Policy lists family history of long QT syndrome as relevant. The patient’s family history includes a mother with long QT syndrome, which is a policy-specified relevant family history.",No,"Policy requires counseling about potential risks of genetic testing by a clinician with genetics expertise. The family declined pre-test genetic counseling and only agreed to post-test counseling, so the policy's pre-test counseling requirement is not met.",81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to clinical exome sequencing and best matches the requested WES.,No,"Although the patient meets the medical indication (multiple congenital anomalies) and prior testing was nondiagnostic, the policy requires ALL criteria be met, including evaluation and pre-test counseling by a clinician with expertise in clinical genetics. That counseling/genetics-evaluation requirement was not met, therefore under the policy the test is not covered.",14831,2109,16940
Case14408,rag,all_incorrect,iter1,BRCA1/2,Patient was referred specifically for BRCA1/2 testing (patient info states BRCA1/2 testing requested).,Not Specified,The provided Cigna hereditary cancer panel policy does not state age-based eligibility for BRCA1/2 single-gene testing in the text supplied; age-specific criteria are not included in this document.,Not Specified,The policy requires pre- and post-test genetic counseling by an appropriate provider but does not specify required ordering provider specialty or other ordering-provider restrictions for BRCA1/2 single-gene requests in the supplied text.,Not Answerable,"Coverage for BRCA1/2 is governed by a separate EviCore 'BRCA Analysis' guideline referenced in the policy; that guideline's specific medical-criteria are not included here, so we cannot determine if the patient meets those BRCA-specific indications from the provided documents.",Yes,"The policy specifies no previous hereditary cancer multigene panel or gene testing is allowed for reimbursement; patient has no prior genetic testing per the provided patient information, satisfying the policy's prior-test requirement.",Yes,"Policy uses family history in eligibility (e.g., meeting BRCA Analysis criteria); patient has a first‑degree relative (brother) with breast cancer, which is relevant per the policy's family-history-based criteria.",Yes,"Policy requires pre- and post-test genetic counseling. Patient had pre-test counseling completed and post-test follow-up with a genetic counselor is planned, satisfying the counseling requirement in the policy.",Not Specified,The supplied policy refers to a separate BRCA Analysis guideline for single-gene BRCA testing and does not provide the specific CPT code for BRCA1/2 in the provided text; the listed CPTs in this document are for panels and other procedures.,No,"The policy states BRCA1/2 coverage is determined by the separate EviCore 'BRCA Analysis' criteria (referenced but not included). Because the required BRCA-specific medical-necessity criteria are not present in the provided policy text and cannot be confirmed from the patient record alone, coverage cannot be confirmed under the supplied policy and thus is not approved based on available documentation.",11858,2408,14266
Case4262,rag,all_incorrect,iter1,WES,Patient information explicitly states diagnostic whole exome sequencing (WES) is being requested.,Not Specified,"The policy does not impose a strict age limit for standard exome sequencing; rapid exome requires ≤12 months (patient is 5 weeks), but the request specifies WES without specifying rapid vs standard, so age-based eligibility for the requested test is not explicitly specified.",Not Answerable,"Policy requires the patient/family history be evaluated by a Board‑Certified/Board‑Eligible Medical Geneticist or an APGN for exome testing. Patient data notes pre‑test genetic counseling and planned genetics follow‑up but does not confirm evaluation by a Board‑Certified/Board‑Eligible Medical Geneticist or APGN, so adequacy of ordering/provider requirements cannot be confirmed.",Yes,"Policy lists 'multiple congenital abnormalities affecting unrelated organ systems' and phenotypes not fitting a well‑described syndrome as an indication for exome sequencing; the five‑week‑old has multiple congenital anomalies not fitting a well‑delineated syndrome, meeting the criterion.",Not Specified,"Policy asks that alternate etiologies be considered and notes exome may be considered after CMA or focused testing is uninformative, but it does not mandate a specific prior test. Patient had a nondiagnostic karyotype; CMA status and other prior testing are not provided.",Yes,"Policy counts a family history strongly suggestive of a genetic etiology as a relevant criterion. The patient has a sibling with an unexplained, concerning event (altered responsiveness, cyanosis, pallor, irregular breathing), which is relevant family history per policy.",Yes,"Policy requires pre‑ and post‑test counseling by an appropriate provider (e.g., Certified Genetic Counselor, Medical Geneticist, or APGN). Patient information states pre‑test genetic counseling was completed and post‑test genetics follow‑up is planned, satisfying the counseling requirement as documented.",81415,"Policy's coding table lists 81415 as the common CPT code for exome sequencing (proband), which corresponds to the requested WES.",No,"Although the clinical phenotype (multiple congenital anomalies) and completed pre‑test counseling support medical necessity under the policy, required documentation is missing for other explicit policy criteria: there is no confirmation the patient/family history were evaluated by a Board‑Certified/Board‑Eligible Medical Geneticist or an APGN (a stated requirement), nor is there documentation that the test result is predicted to impact immediate medical management. Because all required coverage criteria are not documented, the test is not adjudicated as covered.",12239,3960,16199
Case10363,rag,all_incorrect,iter1,WGS,Patient information states whole genome sequencing (WGS) is being pursued after nondiagnostic FISH and targeted testing.,Yes,"Policy eligibility is framed for 'children' with unexplained congenital anomalies; the patient is a 7-year-old child, which meets the age-based 'children' criteria in the policy.",No,"Policy requires the individual be evaluated by a clinician with expertise in clinical genetics (documentation of evaluation including family history and phenotype). Patient data show referral by a general practitioner and genetic counseling visits, but do not document evaluation by a clinician with clinical genetics expertise.",Yes,"Policy medical indication includes unexplained congenital anomalies after prior genetic testing; the patient has a congenital anomaly since birth and prior nondiagnostic targeted testing (FISH), meeting the policy's clinical indication.",Yes,"Policy allows WES/WGS when previous genetic testing failed to yield a diagnosis. Patient had prior targeted testing (FISH) that was nondiagnostic, satisfying the 'previous genetic testing failed to yield a diagnosis' requirement.",No,"Policy lists relevant family-history examples (eg, developmental delay, inborn errors, sudden unexplained death). The patient's family history (maternal aunt with pancreatic cancer) is not among the policy's specified relevant family history criteria.",Yes,"Policy requires genetic counseling by an experienced individual; patient has been seen multiple times by a genetic counselor for pre-test counseling and has plans for post-test follow-up, meeting the counseling requirement.",81425,"The requested test is whole genome sequencing (WGS); among the provided CPT options, 81425 best corresponds to genome sequencing.",No,"Although patient is a child with unexplained congenital anomaly and prior nondiagnostic testing (criteria that support WES), the policy's explicit 'POLICY STATEMENT' indicates that whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations (except rapid WGS for critically ill infants). The requested test is WGS in a non-critically ill child, so per the policy WGS is not covered.",14852,3080,17932
Case9349,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued.,Not Specified,The BCBS_FEP_20443 policy discusses indications for cardiac genetic testing and pediatric considerations but does not set an explicit age cutoff or age-based eligibility criteria for testing.,Yes,"Policy guidance states testing ""should be performed by an expert in genetic testing and/or cardiac ion channelopathies."" The ordering/referring provider is a cardiologist and pre-test counseling was completed by a genetic counselor, which meets the policy's provider/counseling expectations.",Yes,"Policy allows genetic testing when there is suspicion for a channelopathy (eg, family SCD <45) or a moderate-to-high pretest probability after evaluation. The patient has a family history of sudden unexplained death in a close relative <35 and a cardiology referral, meeting clinical indications for cardiac genetic testing per the policy.",No,"Policy states testing for relatives of unexplained SCD should be part of a diagnostic strategy that includes comprehensive history/physical, 12‑lead ECG, exercise stress test, echocardiography, etc. The provided patient information does not document completion of these recommended non‑genetic evaluations.",Yes,"Policy specifies family history (eg, sudden cardiac death in a family member younger than 45) as a relevant indication. The patient has a paternal uncle with sudden unexplained death before age 35.",Yes,"Policy recommends formal genetic counseling by an experienced provider. The patient completed pre-test counseling with a genetic counselor and post-test follow-up plans are confirmed, satisfying the counseling requirement.",81415,The requested test is whole exome sequencing (WES); CPT code 81415 corresponds to exome sequencing (interpretation/report) and is the best match among the provided code options.,No,"Although the patient meets clinical indications (family SCD, cardiology referral) and counseling/provider expectations are met, the policy requires a prior comprehensive clinical (non‑genetic) evaluation before genetic testing is considered. Additionally, the policy emphasizes targeted/mutation‑specific or condition‑focused testing and discourages broad testing of many genes; WES (a broad test) is not specified as covered. Because required prior evaluations are not documented and WES is broader than the policy's recommended targeted approaches, coverage is not supported per the policy.",15898,2312,18210
Case1428,rag,all_incorrect,iter1,WGS,Patient information explicitly states 'whole genome sequencing (WGS) has been ordered.',Yes,"Patient is a three-week-old infant (a child/neonate). Policy references congenital anomalies in infancy (eg, Hirschsprung) and ACMG guidance for congenital anomalies prior to one year; the patient's age falls within these age-related indications.",No,"Policy requires evaluation by a clinician with expertise in clinical genetics AND counseling about testing risks. Although the patient is being evaluated by a medical geneticist (meets expertise), there is no documented pre-test genetic counseling (policy-required), so ordering/provider requirements are not fully met (Policy Statement #1).",No,"The requested test is WGS. The policy's formal Policy Statement limits medically necessary WGS to rapid WGS for critically ill infants in NICU/PICU; for non-critically ill children WGS is stated as investigational. The infant is not documented as critically ill, so the patient does not meet the medical indication for the requested WGS per the policy statement.",Not Specified,"The policy specifies prior testing requirements explicitly for WES (eg, CMA and/or targeted testing or prior testing that failed), but it does not define specific required prior tests for non-rapid WGS in the Policy Statement. The patient had Fragile X testing (nondiagnostic), but the policy does not clearly state required prior tests for the requested WGS.",Yes,"Policy guidelines list family history of developmental delay as a relevant selection criterion. The patient has an older sibling with severe intellectual disability diagnosed by age 18, which meets the family-history criterion in the policy guidelines.",No,"The policy requires that the individual be counseled about the potential risks of genetic testing by a clinician with genetics expertise. The record states there is no documented pre-test genetic counseling, so counseling requirements are not met.",Not Specified,The provided policy document does not list or map CPT codes to WGS/WES testing; therefore a corresponding CPT code is not specified in the policy text.,No,"Under the Policy Statement, WGS is considered investigational for diagnosis in all situations other than rapid WGS for critically ill infants. This infant is not documented as critically ill in NICU/PICU; additionally required pre-test genetic counseling is not documented. Based on the policy statement, the requested WGS is not covered.",14822,3535,18357
Case3359,rag,all_incorrect,iter1,WES,Patient information states whole exome sequencing (WES) is being requested to evaluate an underlying genetic etiology.,Yes,Policy applies to 'children' with unexplained congenital or neurodevelopmental disorders; the patient is 4 years old (a child) and thus meets the age-based application of the WES criteria.,No,"Policy criterion 1 requires documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics.' Patient record states referral by a developmental pediatrician and genetic counseling was provided, but does not document evaluation by a clinician with expertise in clinical genetics, so ordering/provider requirement is not met per policy.",Yes,"Policy medical indication requires unexplained congenital or neurodevelopmental disorder and consideration that a genetic etiology is most likely despite prior testing. The patient has significant hypotonia and developmental concerns (neurodevelopmental disorder) and remains undiagnosed after CMA, meeting the indication.",Yes,"Policy specifies WES may be medically necessary when previous genetic testing (eg, chromosomal microarray analysis) has failed to yield a diagnosis. The patient had a prior CMA that was nondiagnostic, meeting the prior testing requirement.",Yes,"Policy lists family history of developmental delay as relevant. Patient has a sibling with developmental delay, which is relevant family history per the policy.",Yes,"Policy requires counseling about risks of genetic testing by an individual with experience in genetic medicine. Patient had pre-test counseling completed with a genetic counselor on multiple occasions, meeting the counseling requirement.",81415,The requested test is whole exome sequencing; CPT code 81415 corresponds to clinical exome sequencing (WES).,No,"Although the patient meets age, medical indication (neurodevelopmental disorder), prior testing (nondiagnostic CMA), counseling, and has relevant family history, the policy requires ALL criteria including documentation of evaluation by a clinician with expertise in clinical genetics. That specific documentation is not present in the provided patient information, so the policy's ALL-criteria requirement is not satisfied and the test is not covered per the policy.",14846,1806,16652
Case9978,rag,all_incorrect,iter1,WES,Patient information states the 53-year-old is undergoing whole exome sequencing (WES) at the request of the neurologist.,Yes,"Policy age-related eligibility is onset of seizures in early childhood (before age 5). Patient had seizure onset before age 3, which meets the policy's age/onset criterion for early-childhood epileptic encephalopathy.",Not Specified,The policy recommends genetic counseling and testing be performed by experienced individuals but does not specify required ordering provider specialty or provider-type restrictions for ordering the test.,Yes,"Policy medical indication applies to infantile-/early-childhood-onset epileptic encephalopathies with epilepsy as the core symptom. The patient has an epileptic encephalopathy beginning before age 3 and persisting into adulthood, meeting the policy's clinical indication.",Not Specified,"The policy discusses testing strategies (targeted gene testing, panels) and states criteria for WES are in a related evidence review (2.04.102) but does not mandate specific prior tests within this document.",Not Specified,"The policy does not define family history or consanguinity as explicit eligibility criteria for epilepsy genetic testing. While the patient has a brother with an inborn error of metabolism, the policy provides no family-history-based coverage requirement.",Not Specified,"The policy strongly recommends genetic counseling and states it should be performed by experienced personnel, but it does not state counseling as a formal coverage requirement; the patient did complete pre-test counseling per the chart.",81415,Whole exome sequencing corresponds to CPT code 81415 (exome sequencing). The patient specifically requests WES.,Yes,"Under the policy, genetic testing for infantile- or early-childhood-onset epileptic encephalopathy may be considered medically necessary when epilepsy is the core symptom and onset is before age 5. The patient had onset before age 3 and has persistent epileptic encephalopathy; pre-test counseling was completed. These facts align with the policy's medically necessary application.",15067,2503,17570
Case22,rag,all_incorrect,iter1,BRCA1/2,Patient clinical information explicitly states he is undergoing BRCA1/2 testing to evaluate hereditary predisposition.,Not Specified,The provided BCBS_FEP policy text addresses CHEK2/ATM/BARD1 and references a related BRCA1/2 policy but does not include age-based eligibility criteria for BRCA1/2 testing in the supplied document.,Not Specified,The supplied policy discusses genetic counseling but does not specify ordering-provider (specialty/type) requirements for BRCA1/2 testing in the provided text.,Not Specified,"The policy text provided defines medical indications for CHEK2/ATM/BARD1 testing (investigational) and references related BRCA1/2 guidance, but does not include explicit medical indication/coverage criteria for BRCA1/2 in the supplied document.",Not Specified,"The provided policy does not define any required prior tests (e.g., prior gene testing or other diagnostics) that must be completed before BRCA1/2 testing.",Not Specified,"Although the patient has a relevant family history (father with metastatic high-risk prostate cancer), the supplied policy does not state explicit family-history or consanguinity eligibility criteria for BRCA1/2 testing in this document.",Yes,"The provided policy states formal genetic counseling is recommended and should be performed by an individual with expertise; the patient completed pre-test counseling and will return for post-test genetic-counselor follow-up, meeting the policy's counseling expectations.",Not Specified,The supplied policy document does not list or map CPT codes to BRCA1/2 testing; therefore no specific CPT code can be determined from the provided text.,No,"The provided BCBS_FEP policy text does not include coverage criteria or a coverage determination for BRCA1/2 testing (it addresses CHEK2/ATM/BARD1 and labels those as investigational). Because BRCA1/2 coverage criteria are not present in the supplied document, coverage cannot be established from this policy text alone.",11042,3017,14059
Case5605,rag,all_incorrect,iter1,WGS,Patient was referred specifically for whole genome sequencing (WGS). (Patient info: 'referred by an obstetrician for whole genome sequencing (WGS)'),Yes,"Policy: standard WES/WGS medically necessary for pediatrics under 21. Patient is 11 years old, which meets the age criterion (policy I: 'pediatrics under 21 years of age').",Yes,"Policy requires the individual be evaluated by a clinician with expertise in clinical genetics and that counseling was provided. Patient facts: pre-test counseling was completed with a genetic specialist, satisfying the provider/counseling requirement in the policy.",Yes,Policy indication: WES/WGS for evaluation of unexplained congenital disorders in pediatrics when prior genetic testing is non-diagnostic. Patient facts: 11-year-old with a major congenital cardiac anomaly and a nondiagnostic prior CMA — meets the policy medical indication (policy I: 'unexplained congenital ...' and 'Previous genetic testing is non-diagnostic').,Yes,"Policy allows WES/WGS when previous genetic testing is non-diagnostic as one qualifying criterion. Patient facts: prior chromosomal microarray (CMA) was nondiagnostic, which satisfies the prior testing requirement in the policy.",No,"Policy lists specific family-history examples relevant to genetic testing (e.g., arrhythmia, sudden unexplained death, developmental delay). Patient's family history (maternal aunt with pancreatic cancer) is not one of the policy-specified relevant family-history criteria.",Yes,"Policy requires genetic counseling by an experienced clinician. Patient facts: pre-test counseling was completed with a genetic specialist, meeting the policy's genetic counseling requirement.",81425,Policy coding section lists 81425 among covered procedure codes for WES/WGS when medically necessary; 81425 corresponds to whole-genome sequencing in the policy's covered CPT code list.,Yes,"All required policy criteria are met: patient is pediatric (<21), has an unexplained congenital cardiac anomaly, prior CMA was nondiagnostic, and genetic evaluation/counseling was completed by a genetic specialist — therefore standard WGS may be considered medically necessary per policy I.",14852,2597,17449
Case19162,rag,all_incorrect,iter1,WGS,Patient clinical information explicitly states the medical geneticist referred the neonate for whole genome sequencing (WGS).,Not Specified,The provided BCBS_FEP_20459 policy discusses age-related use of CMA in infants/children but does not specify age-based eligibility criteria for whole genome sequencing; WES/WGS are addressed in a separate policy (2.04.102).,Not Specified,The policy discusses genetic counseling and clinical genetic evaluation generally but does not specify ordering-provider (specialty/type) requirements for WGS; WES/WGS are referenced to a different policy.,Not Specified,"This policy defines clinical indications for CMA and states NGS panels are investigational; it does not define medical necessity criteria for whole genome sequencing (WGS), which is addressed in a separate policy.",Not Specified,"The policy outlines a stepwise approach (eg, fragile X and CMA as first-tier) for evaluation of developmental disorders but does not state explicit prerequisite testing requirements for WGS; WES/WGS are covered in another policy.",Not Specified,"Although the patient has a family history of an inborn error of metabolism in a sibling, the provided policy does not specify family-history or consanguinity criteria specific to WGS eligibility in this document.",Not Specified,"The policy recommends formal genetic counseling generally and states it should be performed by experienced personnel, but it does not specify counseling as a formal coverage requirement for WGS in this document; patient has completed pre-test counseling per clinical info.",Not Specified,The policy text provided does not map tests to CPT codes and does not specify which CPT corresponds to whole genome sequencing; CPT options are not referenced in this document.,No,"The BCBS_FEP_20459 policy does not provide coverage criteria for whole genome sequencing (it refers WES/WGS to a separate policy 2.04.102). Because coverage criteria for WGS are not addressed in this provided policy document, coverage cannot be affirmed under this policy.",15712,2374,18086
Case15834,rag,all_incorrect,iter1,WES,Patient information states whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology.,Yes,"Policy applies to 'children' with unexplained congenital or neurodevelopmental disorders; the patient is an infant (a child), therefore age-based eligibility is met per the policy's child-directed criteria.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling. Patient had pre-test counseling with a genetic specialist, satisfying the ordering/provider requirement in policy statement #1.",Yes,"Policy medical indication: WES is medically necessary for unexplained neurodevelopmental disorders in children when all criteria met. The infant has early signs of autism (a neurodevelopmental disorder) and prior targeted genetic testing (Fragile X) was nondiagnostic, meeting the policy's indication requirements.",Yes,"Policy criterion #3 allows WES when previous genetic testing has failed to yield a diagnosis. The patient had prior Fragile X testing that was nondiagnostic, satisfying the prior testing requirement in the policy.",Yes,"Policy guidelines list family history of congenital anomalies as relevant. The patient has a maternal aunt with a congenital anomaly, which is a relevant family history per the policy.",Yes,"Policy requires genetic counseling by an individual with expertise in genetic medicine. Patient completed pre-test counseling with a genetic specialist, meeting the policy's counseling/provider requirement.",Not Specified,The provided policy document does not specify CPT/billing codes for WES; no CPT codes are listed in the policy text supplied.,Yes,"Per policy, standard WES may be considered medically necessary for children with unexplained neurodevelopmental disorders when (1) evaluated and counseled by genetics (met), (2) there is potential for change in management (implied by evaluation for underlying genetic etiology), and (3) prior genetic testing failed to yield a diagnosis (Fragile X nondiagnostic; met). All policy criteria for medical necessity are satisfied.",14827,2425,17252
Case13,rag,all_incorrect,iter1,WES,Patient info states the newborn 'has been referred for whole exome sequencing (WES) after karyotype testing was nondiagnostic.',Not Specified,The provided FEP policy discusses postnatal testing in infants/children but does not state any explicit age-based eligibility criteria for WES.,Not Specified,The policy discusses genetic counseling and follow-up but does not specify ordering-provider specialty or other explicit provider requirements for WES.,Not Specified,"The policy defines indications for chromosomal microarray and states NGS panel testing is investigational; WES (whole exome) is addressed in a separate policy (2.04.102) not provided here, so no medical-indication criteria for WES are present in this document.",No,"Policy indicates a stepwise/tiered approach with CMA (and fragile X testing) as first-tier for multiple congenital anomalies; the patient had a nondiagnostic karyotype but no CMA reported, so required prior testing (CMA/first-tier testing) has not been completed per the policy's recommendations.",Not Specified,"While the patient has a sibling with unexplained developmental regression, the provided policy does not specify family history or consanguinity criteria that would make WES eligible under this document.",Yes,"The policy states experts recommend formal genetic counseling for most cases and that counseling should be performed by someone with genetic expertise; the patient had pre-test genetic counseling completed and post-test follow-up planned, meeting this requirement.",81415,"The requested test is whole exome sequencing (WES); among the provided CPT options, 81415 corresponds to whole exome sequencing.",No,"The FEP policy provided does not establish coverage criteria for WES (WES is addressed in a separate policy not supplied) and classifies NGS panel testing as investigational for the indicated indications; it also designates CMA as the first-line test for multiple congenital anomalies, which has not been completed—therefore WES is not supported for coverage under the provided policy text.",15689,2571,18260
Case16487,rag,all_incorrect,iter1,WES,Patient info states whole exome sequencing (WES) has been ordered by the oncologist.,Yes,"Policy age-related guidance defines BRUE as an event in an infant <1 year and the policy addresses WES in children/infants; the patient is a newborn, so age meets policy-defined infant/child criteria for WES evaluation.",No,"Policy requires documentation that the individual was evaluated by a clinician with expertise in clinical genetics (policy criterion #1). Patient record reports WES ordered by an oncologist but does not document evaluation by a clinical genetics expert, so ordering/provider requirements are not met per policy.",Yes,"Policy lists 'infant with high risk stratification on evaluation for a BRUE with recurrent events without respiratory infection' as an example of clinical features suggesting a genetic disease and WES may be considered when previous genetic testing is nondiagnostic; the patient has high-risk recurrent BRUE and nondiagnostic FISH, so the medical indication criterion is met.",Yes,"Policy criteria note prior genetic testing (e.g., CMA and/or targeted testing) or prior testing failed to yield a diagnosis; the patient had nondiagnostic FISH testing (a prior genetic test), satisfying the policy's prior testing condition.",Yes,"Policy lists relevant family history (e.g., inborn error of metabolism or other genetic disease) among features suggesting a genetic etiology. The patient has a maternal aunt with a severe immunologic/hematologic disorder (a second-degree relative), so a relevant family history is present per policy.",Yes,"Policy explicitly requires documentation of individualized genetic counseling before testing. The patient record states pre-test counseling was completed with plans for post-test genetic follow-up, meeting the counseling requirement.",81415,Policy coding lists CPT 81415 for exome (sequence analysis) which corresponds to WES (proband exome) ordered for this patient.,No,"Although the patient meets age, medical indication (high-risk BRUE, recurrent events without respiratory infection), prior nondiagnostic genetic testing, family history, and has documented pre-test counseling, Blue Cross of Idaho policy requires ALL listed criteria including documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics.' There is no documentation that a clinician with expertise in clinical genetics evaluated the infant (WES was ordered by an oncologist), so the policy's required criteria are not all met and the test is not covered per policy.",56579,2840,59419
Case3677,rag,all_incorrect,iter1,BRCA1/2,Patient is undergoing BRCA1/2 testing per clinical information; the provided policy (AHS–M2003) specifically addresses BRCA1/2 testing and related multi-gene panels.,Yes,Policy requires individuals be ≥18 and lists meeting criteria for breast-cancer cases diagnosed before 51 years (II.2.a.i). Patient is 46 and thus meets the age-based criteria.,Not Specified,The policy requires precertification and genetic counseling but does not define specific ordering-provider specialty requirements; the note that testing must follow counseling is present but no ordering-provider restrictions are specified.,Yes,"Medical-necessity coverage criteria include individuals with personal history of breast cancer diagnosed before age 51 and/or with ≥1 close blood relative with pancreatic cancer (II.2.a.i and II.2.a.i(g)(iv)). The patient has a personal history of breast cancer at age 46 and a close relative with pancreatic cancer, meeting coverage criteria.",Not Specified,The policy does not mandate completion of specific prior tests before BRCA1/2 testing; it notes prior limited testing may affect approach but does not require particular prior tests. Patient's prior nondiagnostic CMA is not specified as a required prior test.,Yes,Policy coverage criteria explicitly consider family history (close blood relative with pancreatic cancer qualifies — Note 1 and II.2.a.i(g)(iv)). The patient has a mother with pancreatic cancer and multiple affected maternal relatives.,Yes,"Policy requires individuals have received genetic counseling prior to testing (II.1 and multiple sections). Patient completed pre-test genetic counseling and plans post-test follow-up, satisfying counseling requirement.",Not Specified,The provided policy document does not list or map specific CPT codes for BRCA1/2 testing; therefore a specific CPT from the given options cannot be determined from policy text.,Yes,"Based on policy AHS–M2003 (II.2.a.i), the patient (age 46 with personal history of breast cancer diagnosed <51 and a close relative with pancreatic cancer) meets coverage criteria for BRCA testing; genetic counseling was completed, so testing is covered.",18254,1827,20081
Case3474,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is being ordered.,Yes,"Policy eligibility is specified for 'children' with unexplained congenital anomalies or neurodevelopmental disorders; the patient is a 5-year-old child, meeting the age-based criterion.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling; the patient was evaluated by a medical geneticist and has had pre-test genetic counseling, meeting ordering/provider requirements.",Yes,"Policy lists unexplained congenital anomalies (choanal atresia is explicitly listed in Policy Guidelines) or neurodevelopmental disorders as indications; the patient has congenital choanal atresia and a sibling with developmental delay, meeting medical indication criteria.",Yes,"Policy requires prior genetic testing that failed to yield a diagnosis (eg, CMA or targeted testing). The patient had prior karyotype testing that was nondiagnostic, which satisfies the policy's requirement that previous genetic testing failed to yield a diagnosis.",Yes,"Policy guidelines specify relevant family history (including developmental delay) as supportive; the patient has an older sibling with developmental delay, meeting family-history criteria.",Yes,"Policy requires genetic counseling prior to testing; the patient has completed pre-test genetic counseling on multiple occasions with plans for post-test follow-up, meeting counseling requirements.",Not Specified,The provided policy document does not specify CPT or billing codes for WGS or related tests.,Yes,"Per the policy, WGS/WES may be considered medically necessary for children with unexplained congenital anomalies when ALL criteria are met. The patient (5 y/o) was evaluated by a genetics specialist, counseled, has a nondiagnostic prior genetic test, has a listed anomaly (choanal atresia) and relevant family history—therefore coverage criteria are met.",14835,2455,17290
Case15938,rag,all_incorrect,iter1,WGS,Patient info states whole-genome sequencing (WGS) is being considered to identify a genetic cholestatic/metabolic etiology.,Yes,"Policy age criterion: WES/WGS indications apply to individuals <18 years. Patient is one week old (<18), so age criterion is met (Policy Section II: criteria for individuals less than 18 years).",No,Policy (II.1.a) requires evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor and counseling; the ordering provider is a neonatologist and no geneticist/genetic counselor involvement is documented.,No,"Policy allows WGS only after WES fails to identify a causative mutation and other criteria are met (II.4). The patient has not had WES yet, so does not meet the policy's specified medical indication for WGS.",No,"Policy requires WES (and negative/non-diagnostic WES) before WGS is covered (II.4 and II.5); patient has nondiagnostic karyotype but no WES performed, so required prior testing has not been completed.",Yes,Patient has a relevant family history: a sibling with unexplained developmental regression. Policy references family/pedigree context (trio testing and prior affected sibling scenarios) as relevant to sequencing indications (Sections II and V).,No,Policy (II.1.a and prenatal guidance) requires pre-test counseling by an ABMGG geneticist or ABGC genetic counselor; no pre-test genetic counseling is documented for this patient.,Not Specified,"The provided policy document does not list or map CPT billing codes to WES/WGS, so a specific CPT code cannot be determined from the policy text.",No,"Per policy, WGS meets coverage only when WES has been performed and failed to identify a causative mutation and when geneticist/genetic counselor evaluation and counseling are documented (II.4 and II.1.a). The patient has not had WES and lacks documented pre-test genetic counseling by an ABMGG/ABGC provider; therefore WGS is not covered.",22474,1820,24294
Case4067,rag,all_incorrect,iter1,WES,Patient clinical information explicitly states whole exome sequencing (WES) has been ordered.,Yes,"Policy applies to 'children' for evaluation of unexplained congenital or neurodevelopmental disorders. The patient is 5 years old, which meets the pediatric/children criterion in the policy.",No,Policy criterion 1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled about risks. The record only notes referral by a developmental pediatrician and does not document a genetics evaluation or genetic counseling; therefore ordering/provider requirements are not met per policy.,Yes,"Policy lists 'significant hypotonia' as a clinical feature suggesting a genetic disease and allows WES for unexplained neurodevelopmental disorders after standard workup. The patient has significant hypotonia and an unexplained disorder, so the medical indication criterion is met.",No,"Policy indicates prior genetic testing such as chromosomal microarray analysis (CMA) and/or targeted single-gene testing is expected as part of the standard workup. The patient had a nondiagnostic chromosomal karyotype but no CMA or targeted testing is documented, so required prior testing has not been demonstrated.",Yes,"Policy lists sudden unexplained death in first- or second-degree relatives before age 35 as relevant family history. The patient has a paternal uncle with sudden unexplained death before age 35, which is a relevant family history per policy.",Not Answerable,"Policy requires genetic counseling by an experienced clinician, but the clinical information provided does not state whether genetic counseling occurred, so adequacy of counseling cannot be determined from the supplied information.",Not Specified,"The provided policy document does not list or map CPT codes to WES. The clinical record requests WES, but no CPT code mapping is specified in the policy text supplied.",No,"Under the policy, standard WES is medically necessary only when ALL criteria are met (including documented genetics evaluation and counseling). The record lacks documentation of evaluation by a clinician with expertise in clinical genetics and genetic counseling (criterion 1) and does not document prior appropriate testing (e.g., CMA) per the standard workup. Therefore not all policy criteria are satisfied and the test is not covered based on the provided information.",14823,2869,17692
Case11514,rag,all_incorrect,iter1,WES,Patient information states whole exome sequencing (WES) has been requested to investigate a potential genetic cause of cholestatic liver disease.,Yes,"Policy Indication #1 explicitly addresses individuals <18 years for WES; the patient is 10 years old, which meets the policy's age criterion for the pediatric indication.",No,"Policy Indication #1(a) requires evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor and counseling about risks; the ordering provider is the patient's oncologist and there is no documentation of geneticist/genetic counselor evaluation, so provider requirements are not met.",No,"The policy's covered pediatric indication (#1) is for 'unexplained congenital or neurodevelopmental disorder' with additional criteria; the patient's presentation is conjugated hyperbilirubinemia/cholestatic liver disease, which is not one of the explicit covered clinical indications listed, so the patient does not meet a defined covered medical indication.",Not Specified,"The policy does not specify mandatory prior tests for non‑fetal, non‑neurodevelopmental pediatric indications; while the patient had a nondiagnostic CMA (noted in policy for some prenatal scenarios), the policy does not define specific prior test requirements for this liver phenotype.",Not Specified,"The policy does not establish family history or consanguinity as a standalone explicit eligibility requirement for the pediatric WES indication; although the patient has a cousin with an inborn error of metabolism, family history criteria are not specified as required in the listed coverage indications.",No,"Policy Indication #1(a) requires the individual has been evaluated by an ABMGG medical geneticist or ABGC genetic counselor and has been counseled about risks; there is no documentation of pre-test genetic counseling, so counseling requirements are not met.",Not Specified,"The provided policy document does not list or map CPT codes to WES or other tests, so a specific CPT code cannot be determined from the policy text alone.",No,"Per the policy, WES coverage for pediatric patients is limited to specific indications (e.g., unexplained congenital or neurodevelopmental disorders) and requires evaluation/counseling by a board-certified geneticist or genetic counselor. The patient's phenotype (cholestatic liver disease) is not one of the explicit covered pediatric indications and pre‑test geneticist/genetic counseling requirements are not documented; therefore WES is not covered under the policy.",22494,2209,24703
Case11981,rag,all_incorrect,iter1,WGS,Patient information explicitly states Whole Genome Sequencing (WGS) is being requested.,Yes,"Policy specifies age-based criteria for pediatric evaluation (<18 years) for genome/exome sequencing; the patient is 9 years old, meeting the age criterion (policy Section II.1: ""individuals less than 18 years of age"").",Not Answerable,"Policy requires evaluation/counseling by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor (Section II.1.a). The chart states a ""pre-test discussion with a genetic specialist"" but does not document the provider's ABMGG/ABGC certification, so sufficiency cannot be confirmed from the provided information.",No,"Policy allows WGS only when WES was unable to identify a causative mutation and clinical suspicion remains (Section II.4). The patient has not had WES per the provided information, so the policy-defined medical indication for WGS is not met.",No,Policy requires WES (and/or prior tests) before WGS when clinical criteria apply (Section II.4 and II.5). The patient has had fragile X testing but has not had WES; therefore the required prior test (WES) before WGS has not been completed.,Not Specified,"The policy does not list family history/consanguinity as a specific mandatory eligibility criterion for pediatric WGS in Section II.1; although the patient has a maternal uncle with an immunologic disorder, the policy's core WGS/WES pediatric criteria do not hinge on this family history.",Not Answerable,"Policy requires pre-test counseling by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor (Section II.1.a). The record notes a pre-test discussion with a ""genetic specialist"" but does not document the required ABMGG/ABGC credentialing or that counseling covered the required elements, so this cannot be confirmed.",81425,The requested test is Whole Genome Sequencing (WGS); CPT code 81425 corresponds to WGS (best match for the requested whole-genome test).,No,"Per policy, WGS MEETS COVERAGE CRITERIA only when WES was performed and unable to identify a causative mutation and clinical suspicion persists (Section II.4). The patient has not had WES (only fragile X testing), and required prior testing/sequence pathway has not been satisfied; therefore WGS is not covered under the policy for this request.",22479,2160,24639
Case7682,rag,all_incorrect,iter1,WES,Patient record explicitly states 'whole exome sequencing (WES) is being requested'.,Yes,"Policy applies to 'children' with unexplained congenital or neurodevelopmental disorders; patient is a 9-year-old child, which meets the pediatric age applicability in the policy.",Yes,"Policy requires the individual be evaluated and counseled by a clinician with expertise in clinical genetics. Patient had pre-test counseling completed with a genetic specialist, satisfying the ordering/evaluation requirement.",Yes,"Policy medical indication: unexplained congenital or neurodevelopmental disorders in children when criteria met. The patient has multiple congenital abnormalities and developmental concerns with a likely genetic etiology and prior nondiagnostic genetic testing (karyotype), meeting the policy's clinical criteria.",Yes,Policy criteria allow WES when 'previous genetic testing has failed to yield a diagnosis.' Patient had prior nondiagnostic karyotype; this prior testing failed to yield a diagnosis per the chart.,Yes,Policy lists family history of developmental delay as a relevant factor. Patient has a sibling with developmental delay documented in the clinical information.,Yes,"Policy requires genetic counseling by an experienced individual and counseling about risks; patient had pre-test counseling with a genetic specialist and plans for post-test follow-up, meeting counseling requirements.",81415,Requested test is whole exome sequencing (WES); CPT 81415 corresponds to clinical exome sequencing and is the appropriate code among the provided options.,Yes,"Under the policy, standard WES may be considered medically necessary for children with unexplained congenital or neurodevelopmental disorders when all criteria are met. The patient is a child with multiple congenital anomalies, prior nondiagnostic genetic testing, documented genetics evaluation and counseling, and family history—thus meeting the policy criteria for coverage.",14826,2259,17085
Case3494,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being requested for diagnostic clarification.,Yes,Policy allows WES for children with unexplained congenital anomalies or neurodevelopmental disorders; the infant is 6 weeks old (an infant) and thus within the pediatric age range referenced by the policy (including infants).,No,"Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics and counseling about risks. Patient facts indicate referral by a general pediatrician and that genetic counseling was declined, so the policy-required genetic evaluation/counseling requirement is not met.",No,"Policy requires ALL criteria including prior genetic testing considerations (eg, CMA and/or targeted single-gene testing) or previous testing failure before standard WES in non-critically ill children. The patient has no prior genetic testing documented, so the specified medical indication criteria are not met.",No,"Policy lists prior testing (eg, chromosomal microarray and/or targeted single-gene testing) as part of the criteria for standard WES in non-critically ill children; the patient has had no prior genetic testing.",Yes,Policy guidance lists relevant family history items as part of evaluation. The patient has a sibling with dysmorphic features (a positive family history relevant to a suspected genetic disorder).,No,"Policy explicitly states genetic counseling should be performed by someone with expertise; the family declined genetic counseling, so the policy-required counseling criterion is not satisfied.",81415,The requested test is whole exome sequencing (WES); CPT code 81415 corresponds to clinical exome/exome sequencing and is the best match among the provided code options.,No,"Per the policy, standard WES is medically necessary only when ALL criteria are met (including evaluation by a clinical genetics expert with counseling and prior appropriate genetic testing unless critically ill). The infant is not documented as having been evaluated/counseled by a genetics expert, genetic counseling was declined, and no prior genetic testing (eg, CMA) was performed; therefore coverage criteria are not met.",14828,2383,17211
Case7014,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is being requested to identify an underlying genetic etiology.,Yes,"Policy addresses children and infants (including infants <1 year) with multiple congenital anomalies; the patient is a 7‑week‑old infant, which satisfies the age population described in the policy for exome/genome testing.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling. The record documents pre‑test genetic counseling with a genetic specialist and neurology referral, meeting the ordering/provider requirement in the policy.",Yes,"Policy lists multiple congenital anomalies of unknown etiology as a medical indication for exome/genome testing; the patient has multiple congenital anomalies that do not fit a well‑delineated syndrome, meeting the clinical indication.",No,"Policy expects a standard workup (examples include chromosomal microarray analysis and/or targeted single‑gene testing) prior to WES/WGS. The patient had a nondiagnostic karyotype but no documentation of CMA or targeted single‑gene testing, so the required prior testing is not documented as completed.",Yes,"The policy lists family history (examples include genetic disease or related findings) as relevant. The patient has a maternal aunt with a congenital anomaly, which constitutes a relevant family history per the policy guidance.",Yes,"Policy requires genetic counseling by someone with expertise; the record states pre‑test genetic counseling was completed with a genetic specialist, fulfilling the counseling requirement.",Not Specified,The provided policy document does not specify CPT or billing codes for WGS; therefore a corresponding CPT code is not specified in the policy text.,No,"Although the patient is an infant with multiple unexplained congenital anomalies, has genetics counseling, and was evaluated by specialty clinicians (many policy criteria met), the policy requires documentation of prior standard genetic workup (eg, CMA and/or targeted single‑gene testing) or equivalent. Only a nondiagnostic karyotype is documented and CMA/targeted testing is not documented; because not all required criteria are met per the policy, the WGS request is not covered.",14836,35536,50372
Case13517,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) was ordered to evaluate for an underlying genetic cause.,Yes,"Policy applies to 'children' for standard WES; the patient is 16 years old, which meets the policy's child age context for WES.",No,"Policy criterion 1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. Patient was referred by a developmental pediatrician and had genetic counseling, but there is no documentation the patient was evaluated by a clinician with expertise in clinical genetics as required by the policy.",No,Policy limits medical necessity to evaluation of unexplained congenital or neurodevelopmental disorders in children (standard WES). The record documents conjugated hyperbilirubinemia and a sibling with possible inborn error of metabolism but does not document an unexplained congenital or neurodevelopmental disorder in this patient that meets the policy's specified indication.,No,"Policy criterion 3 expects prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or prior testing that failed to yield a diagnosis. The patient only had Fragile X testing (nondiagnostic); there is no documentation of CMA or appropriate targeted testing having been completed.",Yes,"Policy lists family history of an inborn error of metabolism as relevant. The patient has a sibling with laboratory abnormalities suggestive of an inborn error of metabolism, which matches the policy's family-history criterion.",Yes,"Policy requires counseling (evaluation and counseling about risks). The patient had pre-test counseling with a genetic counselor and post-test counseling is planned, satisfying the policy's genetic counseling requirement.",81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to clinical exome/whole exome sequencing and is the best-matching code among the options.,No,"Under the policy standard WES is medically necessary only when ALL criteria are met (evaluation by clinician with expertise in clinical genetics, potential to change management, and prior testing criteria). The record lacks documentation of evaluation by a clinician with expertise in clinical genetics and lacks evidence of required prior testing (eg, CMA/targeted testing), so the policy's ALL-criteria requirement is not met and the test is not covered per this policy.",14844,3003,17847
Case14127,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy applies to children; patient is 17 years old (under 18), satisfying 'children' criteria for WES per the policy and ACMG guidance cited in the policy.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling; patient was referred to medical genetics, the medical geneticist is coordinating testing, and pre-test genetic counseling occurred.",Yes,"Policy requires unexplained congenital or neurodevelopmental disorder; patient has global developmental delay/lifelong cognitive and adaptive deficits (a neurodevelopmental disorder) and the phenotype is unexplained, meeting the medical indication in the policy.",Yes,"Policy allows WES when previous genetic testing has failed to yield a diagnosis; patient had prior FISH testing that was nondiagnostic, meeting the 'previous testing failed' criterion.",Yes,"Policy notes family history (eg, developmental delay, epileptic disorders) as relevant; patient has a sibling with early-onset epileptic encephalopathy, which is relevant per the policy.",Yes,"Policy requires genetic counseling/documentation of counseling; patient saw a genetic counselor for pre-test counseling and will return for post-test counseling, meeting counseling requirements.",Not Specified,The provided policy document does not specify CPT/billing codes for WES; no CPT guidance is given in the policy text.,Yes,"Per the policy, standard WES may be considered medically necessary for children with unexplained neurodevelopmental disorders when ALL criteria are met. Patient (17yo) meets criteria: evaluated by genetics and counseled, unexplained neurodevelopmental disorder, prior genetic testing nondiagnostic, and potential for management change implied by genetic diagnosis.",14856,1743,16599
Case15820,rag,all_incorrect,iter1,CMA,Patient information states a chromosomal microarray (CMA) has been ordered. Basis: patient clinical info.,Not Specified,"Policy lists CMA as medically necessary for 'individuals' with nonsyndromic developmental delay/intellectual disability but does not set an explicit age cutoff; although the document discusses children/infants, no explicit age-based eligibility criteria are stated. Basis: FEP 2.04.59 policy statement and guidelines.",Not Specified,The policy does not specify required ordering provider specialty or credentials for CMA. Basis: FEP 2.04.59 contains no ordering-provider requirement language.,Yes,Patient has nonsyndromic developmental delay and intellectual disability; policy explicitly states CMA may be considered medically necessary as first-line testing for apparent nonsyndromic developmental delay/intellectual disability. Basis: FEP 2.04.59 policy statement.,Not Specified,"Policy allows CMA as first-line testing in the initial evaluation, so no specific prior tests are required before CMA in the policy. Basis: FEP 2.04.59 policy statement and guidelines (CMA as first-line).",Not Specified,The policy does not define family history or consanguinity criteria as requirements for CMA eligibility. Patient's family history (mother with early breast cancer) is not referenced as relevant in this policy. Basis: FEP 2.04.59 content.,Yes,"Policy states experts recommend formal genetic counseling and that genetic counseling 'should be performed' by experienced individuals. Patient completed multiple pre-test counseling sessions with a genetic counselor and has plans for post-test follow-up, meeting the policy's counseling expectations. Basis: 'Genetic Counseling' section of FEP 2.04.59.",Not Specified,The policy document does not specify CPT or billing codes for CMA testing. Basis: FEP 2.04.59 contains no CPT code mapping.,Yes,Patient meets the policy's coverage criteria: nonsyndromic developmental delay/intellectual disability qualifies CMA as medically necessary as a first-line test; patient has no prior testing required and has undergone pre-test genetic counseling per policy recommendations. Basis: FEP 2.04.59 policy statement and genetic counseling guidance.,15697,1780,17477
Case13675,rag,all_incorrect,iter1,WGS,The patient information states 'whole genome sequencing (WGS) is being pursued.',Yes,"Policy age-related language specifies applicability to 'children' and infants with congenital anomalies; the patient is an 8‑week‑old infant, which meets the policy's child/infant age criteria for evaluation of congenital anomalies.",No,"Policy REQUIREMENT #1: documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled about risks. The ordering/referring provider is a neonatologist and there is 'no documentation of pre‑test genetic counseling' or genetics evaluation, so provider/counseling requirements are not met per the policy.",Yes,"Policy medical indications include evaluation of unexplained congenital anomalies; the patient has significant congenital hearing and/or visual impairment and prior genetic testing (FISH) was nondiagnostic, meeting the policy's clinical indication for genome/exome sequencing.",No,"Policy notes prior testing such as chromosomal microarray analysis (CMA) and/or targeted single‑gene testing should have been performed or failed to yield a diagnosis. Only prior FISH (nondiagnostic) is documented; CMA/targeted testing is not documented, so required prior testing is not shown.",Yes,"Policy explicitly lists family history items relevant to consideration, including Long QT syndrome; the patient's father has long QT syndrome, which is a relevant family history per the policy.",No,"Policy explicitly requires genetic counseling performed by someone with genetics expertise prior to testing (documentation required). The record states there is no documentation of pre‑test genetic counseling, so counseling requirements are not met.",Not Specified,The provided FEP policy document does not list or specify CPT/billing codes for WGS or related tests; thus a specific CPT code is not specified in the policy text.,No,"Per the policy statement, whole genome sequencing is considered investigational for diagnosis in all other situations except when rapid WGS is medically necessary for critically ill infants who meet specific ICU criteria. The patient is not documented as critically ill in NICU/PICU and WGS pre‑requirements (genetics evaluation, genetic counseling, prior recommended testing such as CMA) are not met; therefore WGS is not covered under this policy.",14847,2358,17205
Case2162,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) was requested to evaluate multiple congenital anomalies.,Yes,"Policy age-based coverage for WES/WGS applies to individuals <18 years; the patient is 7 weeks old, meeting the <18 years criterion referenced in the policy (see Indications #1 and #4 linking WGS to the <18 criteria).",Not Answerable,"Policy (Indications #1a) requires evaluation by an ABMGG board‑certified medical geneticist or an ABGC board‑certified genetic counselor for WES (and WGS is contingent on WES criteria). The record notes pre‑test counseling and GP referral but does not state the counselor's certification or that an ABMGG geneticist evaluated the patient, so sufficiency cannot be confirmed from available information.",No,"Policy defines WGS coverage only when WES was unable to identify a causative mutation and the other WES criteria are met (Indication #4). The patient has congenital anomalies consistent with an indication for WES, but WES has not been reported as performed/negative, so the specific medical indication for WGS per policy is not met.",No,Policy requires prior WES (and meeting WES criteria) before WGS coverage (Indication #4). Patient has only nondiagnostic Fragile X testing reported; there is no documentation of prior WES having been completed and nondiagnostic.,Not Specified,"Policy does not require family history or consanguinity as a distinct eligibility criterion for WGS; although the patient has an older sibling with ASD, the policy does not list family history/consanguinity as a required element for WGS coverage in this scenario.",Not Answerable,"Policy requires pre‑test counseling by an ABMGG geneticist or ABGC board‑certified genetic counselor for WES (Indication #1a) and WGS coverage is contingent on WES criteria. The record states pre‑test counseling was completed but does not document the counselor's certification, so compliance with the policy's counseling/provider requirement cannot be confirmed.",Not Specified,The provided policy document does not list or map specific CPT billing codes to WES/WGS; therefore a CPT code cannot be determined from the policy text alone.,No,"Per policy, WGS only meets coverage criteria after WES is unable to identify a causative mutation and the WES criteria are met (Indication #4). The patient has not had documented WES (only nondiagnostic Fragile X), so WGS as requested does not meet the coverage criteria.",22452,2685,25137
Case7376,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered for diagnostic clarification.,No,The policy's Clinical Guideline Coverage Criteria explicitly considers WES/WGS medically necessary for members under 18 in an outpatient setting; the patient is 73 and therefore does not meet the age-based eligibility in the policy.,Not Answerable,"The policy requires WES/WGS be ordered by a board-certified medical geneticist or a board-certified physician with specialty in the condition being tested. Patient info only states the order came from a 'neurologist' and does not confirm board certification, so adequacy vs. the policy requirement cannot be determined from provided data.",Yes,"The policy's overview states WES/WGS may be appropriate when there is no known cause of a patient's symptoms and conventional testing is nondiagnostic or targeted testing is unlikely to provide a diagnosis. The patient has an unexplained major abnormality and prior FISH testing was nondiagnostic, which aligns with those described medical indications.",Not Specified,The policy requests documentation of prior conventional diagnostic testing if performed but does not mandate specific prior tests as an absolute precondition for WES (it even states conventional diagnostic testing is not required prior to WGS). Thus specific required prior testing is not defined; the patient did have nondiagnostic FISH.,Yes,"The policy requires submission of the member's family history (three-generation pedigree) as part of the request; the patient reports a sister with triple-negative breast cancer, which is a relevant family history per the policy's documentation requirements.",Yes,"The policy requires pre- and post-test genetic counseling by an appropriate genetics professional. The patient information states pre-test counseling was completed with a genetic specialist, satisfying the counseling requirement.",81415,"The policy's CPT code table lists 81415 for exome sequence analysis (e.g., unexplained constitutional or heritable disorder), which corresponds to WES ordered for this patient.",No,"Although the patient's presentation meets the policy's described medical indications (unexplained symptoms, prior nondiagnostic testing, genetics counseling completed), the policy's formal coverage criteria limit coverage to members under 18 in an outpatient setting. The patient is 73, and the policy states the Plan will not cover WES/WGS for members who do not meet the criteria above, so the test is not covered under this policy.",5341,2638,7979
Case11124,rag,all_incorrect,iter1,WES,Patient information explicitly states whole-exome sequencing (WES) has been ordered.,Yes,"Policy age criteria include developmental delay/intellectual disability with onset prior to age 18 years (Standard ES I.A.2.a). The patient is an infant with developmental delay, which meets the age-based eligibility in the policy.",Not Answerable,"The policy specifies evaluation/counseling by an appropriate genetics provider (Board-Certified/Board-Eligible Medical Geneticist or APGN) (Standard ES I.F and I.G), but the patient data do not state whether the ordering/referring provider or evaluator meets those specified provider requirements.",Yes,"Policy medical indications include unexplained developmental delay/intellectual disability with onset before age 18 (Standard ES I.A.2.a) and family history suggestive of a genetic etiology. The infant has developmental delay and a sibling with childhood hearing impairment, meeting these clinical indications.",Not Specified,"The policy does not mandate a specific prior test universally (it notes exome may be considered after CMA or focused testing are unrevealing), and the patient record only documents nondiagnostic FISH; the policy's prior-testing requirements are not explicitly defined for this scenario.",Yes,"Policy lists 'family history strongly suggestive of a genetic etiology' as a qualifying criterion (Standard ES I.A.2.b and Rapid ES I.C.2.f). The patient has an older sibling with significant childhood hearing impairment, which is relevant and supportive.",Not Answerable,"The policy requires pre- and post-test counseling by an appropriate provider (Standard ES I.F). The patient record states pre-test counseling was completed and post-test counseling is planned but does not document the credential of the counseling provider, so it cannot be confirmed the counseling met the policy's provider requirements.",81415,CPT 81415 is listed in the policy as a common code for standard exome sequencing (Standard Exome Sequencing section and Policy Reference Table).,No,"While the patient meets clinical indication (developmental delay, relevant family history) and age criteria, the policy requires evaluation and counseling by specified genetics providers (Standard ES I.F and I.G). The provided information does not document that the required genetics evaluation/provider credentials were met, so required coverage criteria are not fully demonstrated in the record and coverage cannot be confirmed per the policy.",12227,1867,14094
Case8051,rag,all_incorrect,iter1,WES,Patient clinical information explicitly states whole exome sequencing (WES) was ordered.,Not Specified,The policy discusses pediatric testing considerations but does not define explicit age cutoffs or age-based eligibility criteria for WES or channelopathy testing; no specific age-based requirement is specified in the policy.,No,"Policy Guidelines state genetic testing ""should be performed by an expert in genetic testing and/or cardiac ion channelopathies."" The ordering provider is a family medicine physician (not documented as such an expert), so provider requirements in the policy are not met.",No,"Policy defines medical indications for genetic testing limited to suspected channelopathies (eg, LQTS, CPVT, BrS, SQTS) with specific clinical signs/symptoms or family history. The patient has a major congenital cardiac anomaly (structural) but no documented signs/symptoms or ECG/stress-test findings consistent with a channelopathy, so the patient does not meet the policy's specified clinical indications.",No,"Policy states evaluation for channelopathies should include history/physical and ECG, exercise stress test, transthoracic echocardiography, etc., before or as part of the diagnostic strategy. The record only documents a nondiagnostic FISH; required prior cardiac/channelopathy evaluations are not documented as completed.",No,"Policy specifies family-history criteria for testing (eg, close relative with known variant or clinical diagnosis). The patient’s history notes a mother with short stature (concern for growth-related condition) but no family history of a cardiac channelopathy or known pathogenic variant; thus the policy's family-history criteria are not met.",Yes,"Policy recommends genetic counseling performed by someone with expertise. The patient/family completed pre-test genetic counseling and will follow up after results, meeting the policy's counseling expectation.",Not Specified,The provided policy document does not list or map CPT codes to tests (WES/WGS/panels); therefore a specific CPT code cannot be determined from the policy text.,No,"Based on policy: testing is covered when directed at suspected cardiac ion channelopathies with specified clinical criteria and performed by experts; WES here is broad, ordered by a non-expert, lacks documented channelopathy indications or required prior cardiac testing, and policy excludes panels/tests when included tests are not covered or are investigational. Therefore WES as requested is not covered under this policy.",15895,8821,24716
Case19905,rag,all_incorrect,iter1,WES,Patient is explicitly being considered for whole exome sequencing (WES) per the clinical information.,Not Specified,The policy refers to use of WES in 'children' but does not give a specific numeric age cutoff; the patient is 3 years old but no explicit age-based criterion is specified in the policy.,No,"Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics and documentation of counseling; the record shows referral by a developmental pediatrician and no documented genetics evaluation or counseling, so ordering/provider requirements are not met per the policy.",Yes,"Policy states WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient has multiple congenital anomalies, meeting this clinical indication.",No,"Policy examples specify prior genetic testing (e.g., chromosomal microarray analysis and/or targeted single-gene testing) or prior testing failed and invasive procedures would be next. Only a nondiagnostic karyotype is documented; CMA/targeted testing is not documented, so required prior testing is not shown.",Yes,"Policy lists family history items relevant to selection (including long QT syndrome). The patient has a mother with long QT syndrome, meeting the family-history-relevant criterion.",No,"Policy criterion #1 requires that the individual be counseled about potential risks of genetic testing by a clinician with genetics expertise; the record states no genetic counseling has been conducted, so the counseling requirement is not met.",81415,The requested test is whole exome sequencing; CPT code 81415 corresponds to exome sequencing and is the best match among options.,No,"Although the patient meets the clinical indication (multiple congenital anomalies) and has relevant family history, the policy requires ALL criteria to be met (including genetics evaluation/counseling and appropriate prior testing such as CMA/targeted testing). Those required elements are not documented, so per the policy the test is not covered as presented.",14808,2106,16914
Case10850,rag,all_incorrect,iter1,WGS,Patient clinical info explicitly states whole genome sequencing (WGS) has been ordered.,Yes,"Policy age-based criteria apply to individuals <18 for evaluation of unexplained neurodevelopmental disorders; patient is 13, which meets the <18 requirement (see Policy II.1).",Not Answerable,"Policy (II.1.a) requires evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor; the record notes evaluation by a developmental pediatrician and pre-test counseling but does not specify the counselor’s ABGC/ABMGG credentials, so provider requirement compliance cannot be confirmed from available info.",No,"Policy limits coverage of WGS to situations where WES was performed and unable to identify a causative mutation and the WES criteria are met (II.4). The patient has not had prior WES documented, so the medical indication for WGS per policy is not met.",No,Policy requires WES (and comparator analysis) prior to WGS when WES is nondiagnostic (II.4). The patient has only had nondiagnostic FISH; no prior WES is documented.,Yes,Patient has a relevant family history (an aunt with dysmorphic features). The policy recognizes family history as relevant to assessing a likely genomic etiology in genetic testing contexts (multiple sections discussing family history and inherited phenotypes).,Not Answerable,"Policy requires pre-test counseling by an ABMGG geneticist or ABGC genetic counselor for WES/WGS indications (II.1.a). The record states pre-test genetic counseling was completed but does not document the counselor’s ABGC credential, so compliance cannot be confirmed.",Not Specified,The provided policy document does not list or map specific CPT codes to WGS/WES testing; no CPT guidance is present in the text.,No,"Under the policy WGS MEETS COVERAGE CRITERIA only when WES has been performed and failed to identify a causative mutation and all relevant WES criteria are met (II.4). Because no prior WES is documented for this patient, the requested WGS is not covered per policy.",22462,2659,25121
Case19321,rag,all_incorrect,iter1,WES,Patient info explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy requires member <21 years of age for exome sequencing; patient is 1 year old, meeting the age criterion (policy: 'Member is <21 years of age').",Not Specified,The policy requires an appropriate genetic and family history evaluation and a clinical letter but does not specify a mandatory ordering provider specialty for coverage; no explicit ordering-provider restriction is stated.,No,"Policy requires ALL listed indication elements (including that a genetic etiology is the most likely explanation and meeting one of the specific phenotype pathways such as formal global developmental delay or TWO specified criteria). The record documents 'features concerning for autism' and 'complex neurodevelopmental disorder' but does not document the formal diagnostic criteria (e.g., formal GDD assessment in ≥2 domains or two items from the 'TWO of the following' list) or an explicit clinical letter stating genetic etiology is most likely, so the specific medical-indication criteria are not met per policy.",Yes,"Policy requires prior testing information and that initial testing be unrevealing before ES; patient had prior chromosomal microarray (CMA) testing that was nondiagnostic, which satisfies the documented prior testing requirement in the policy.",Yes,"Policy requires an appropriate genetic and family history evaluation. The patient has a relevant family history (maternal aunt with multiple congenital anomalies), which is supportive and relevant to eligibility under the policy's requirement for family history evaluation.",Yes,"Policy and ACMG guidance recommend pretest genetic counseling by genetics professionals; the patient had pre-test genetic counseling completed and plans for post-test follow-up, meeting the counseling expectation in the policy.",81415,Policy maps exome sequencing for the proband to CPT 81415 ('81415 should be billed for the proband').,No,"Although age, prior CMA nondiagnostic, pre-test counseling, and family history are consistent with policy expectations, the exome guideline requires ALL specified criteria (including documentation that a genetic etiology is the most likely explanation and meeting one of the detailed phenotype pathways with required formal assessments/documentation). The provided clinical information does not document those required clinical-letter elements or that the patient meets the specific phenotype criteria per policy, so coverage criteria are not fully met.",10482,3074,13556
Case2496,rag,all_incorrect,iter1,WES,Patient information explicitly states a request for whole exome sequencing (WES) for a prenatal evaluation at 32 weeks.,Yes,The policy includes specific fetal WES criteria (Section II.2) for a fetus with ultrasound anomalies; the patient is a fetus at 32 weeks so age/gestational status meets the policy's prenatal (fetal) indication.,No,Policy (Section II.2.a) requires pre-test counseling provided by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor; the ordering provider is a neonatologist and no genetic counseling has been completed per the patient information.,No,"Fetal WES coverage (Section II.2) requires all listed criteria (including pre-test counseling and prior CMA/karyotype nondiagnostic). The patient lacks documented CMA/karyotype testing (only nondiagnostic FISH) and lacks the required pre-test genetic counseling, so the specified fetal criteria are not met.",No,Policy (Section II.2.b) requires that standard chromosomal microarray (CMA) and karyotype have failed to yield a diagnosis prior to fetal WES. The patient has only prior fluorescence in situ hybridization (FISH) reported as nondiagnostic; CMA and karyotype are not documented.,Yes,"The policy and incorporated guidelines (ISPD/SMFM text within the policy) include family-history based scenarios and parental carrier/consanguinity considerations for prenatal sequencing. The patient has documented parental consanguinity and a family history (sibling sudden unexplained death), which are relevant per those policy-discussed criteria.",No,The policy (Section II.2.a) explicitly requires pre-test counseling by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor for fetal WES; the patient information states no genetic counseling has been completed.,Not Specified,The provided policy document does not specify CPT or billing codes for WES; no CPT mapping is included in the policy text.,No,"Under the policy, fetal WES only 'MEETS COVERAGE CRITERIA' when all required conditions are met (Section II.2). The patient lacks required pre-test counseling by a board-certified geneticist/counselor and lacks documented prior CMA/karyotype testing; therefore the request does not meet the policy's coverage criteria.",22482,2381,24863
Case6867,rag,all_incorrect,iter1,BRCA1/2,Patient clinical information explicitly states she presents for BRCA1 and BRCA2 testing.,Not Specified,The provided FEP policy (2.04.126) does not specify age-based eligibility criteria for BRCA1/2 testing; it references related policy 2.04.02 for BRCA testing but no age limits are given in the supplied text.,Not Specified,The provided policy discusses genetic counseling and recommends experienced counselors but does not define specific ordering-provider type or specialty requirements for BRCA1/2 ordering in the supplied text.,Yes,"Within the provided document the American Society of Breast Surgeons statement (included in the policy) says genetic testing should be made available to all individuals with a personal history of breast cancer and should include BRCA1/BRCA2; the patient has a personal history of breast cancer, meeting that clinical indication.",Not Specified,"The policy notes that testing an affected family member first is ideal and references NCCN criteria, but it does not mandate specific prior tests that must be completed before BRCA1/2 testing in the supplied text.",Yes,"The policy emphasizes family history in risk assessment (references NCCN and other guidance). The patient has relevant family history (mother with breast cancer at age 50 and a brother with metastatic prostate cancer with intraductal features), which is pertinent to hereditary breast/ovarian cancer evaluation per the policy.",Yes,"The policy states genetic counseling is recommended and should be performed by an experienced provider; the patient had multiple pre-test counseling visits with a genetic counselor, satisfying the counseling expectation described in the policy.",Not Specified,"The provided policy text does not list or map specific CPT codes to BRCA1/2 testing, so a corresponding CPT code is not specified in the supplied document.",Yes,"Under the Benefit Application the policy states benefits are available for specialized diagnostic genetic testing when medically necessary to diagnose/manage a patient's existing medical condition. Additionally, the included American Society of Breast Surgeons guidance in the policy supports offering BRCA1/2 testing to individuals with a personal history of breast cancer. The patient has a personal history of breast cancer, documented genetic counseling, and relevant family history; therefore, per the provided policy text BRCA1/2 testing would be covered as medically necessary.",11017,2115,13132
Case1130,rag,all_incorrect,iter1,WES,Patient clinical info states the patient is 'undergoing whole exome sequencing (WES) to assess for an underlying genetic etiology.',No,"Policy limits medically necessary epilepsy genetic testing to patients with seizure onset in early childhood (before age 5). Patient is 68 years old, so does not meet the policy's age/onset criterion (Policy: 'onset of seizures in early childhood (i.e., before the age of 5 years)').",Not Specified,The policy does not specify required ordering provider specialty or type for epilepsy genetic testing; it only recommends genetic counseling by qualified personnel but gives no explicit ordering-provider requirement.,No,"Medically necessary criteria are defined for infantile-/early-childhood-onset epileptic encephalopathies (onset <5 years, clinically severe, etc.). The patient is an adult (68) with persistent seizures and no documentation of early-childhood onset or meeting the listed syndrome criteria, so the patient does not meet the policy's defined medical indications.",Not Specified,"The policy discusses testing strategies (targeted gene testing, panels, WES per MP 2.324) but does not explicitly require specific prior tests before WES in this document; therefore required prior testing is not specified here (patient did have nondiagnostic FISH, but policy does not mandate FISH prior to WES).",Not Specified,The policy does not set family history or consanguinity requirements for epilepsy WES; the patient's reported family history (sister with ovarian/fallopian/peritoneal carcinoma) is not addressed as relevant in this policy.,Yes,"Policy recommends formal genetic counseling by an individual with expertise when genetic testing is considered. Patient has 'seen a genetic counselor multiple times with plans for post-test follow-up,' meeting the policy's counseling expectation.",81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to clinical exome sequencing interpretation/report and best matches WES among the provided options.,No,"Under the policy, genetic testing for epilepsy is medically necessary only for infantile-/early-childhood-onset epileptic syndromes (onset <5 years) with other specified criteria. The patient is 68 with no documentation of seizure onset in early childhood, so the request does not meet the policy's coverage criteria and is not covered per this policy.",16924,1936,18860
Case5303,rag,all_incorrect,iter1,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing per clinical information; policy MOL.TS.238.A addresses BRCA1/2 analysis.,Yes,"Policy age requirement for BRCA testing is >=18 years for known familial, founder, full sequence and deletion/duplication analyses; patient is 37, which meets the >=18 requirement (policy: 'Age 18 years or older').",Not Specified,"Policy requires pre- and post-test genetic counseling by an appropriate provider and that the rendering laboratory be qualified, but it does not specify a required ordering provider specialty or that neurology cannot order; therefore specific ordering-provider specialty requirements are not defined.",No,Policy defines clinical indications (personal history of specified cancers or specific family-history combinations). The patient has no personal history of breast/ovarian/pancreatic/prostate cancer and a brother who died suddenly (no cancer); this does not meet the policy's diagnostic or personal/family-history combination criteria for BRCA testing.,Yes,"Policy prior-testing requirements state tests are allowable when there is 'No previous full sequencing' or 'No previous deletion/duplication analysis' as applicable; the patient has had no prior genetic testing, satisfying the 'no previous testing' requirements described in the guideline.",No,"Policy family-history criteria require relatives with breast, ovarian, pancreatic, prostate cancer or a known familial BRCA mutation. The patient's only noted family history is a brother who died suddenly without reported cancer, which does not satisfy the policy's family-history criteria.",No,"Policy explicitly requires pre- and post-test genetic counseling for BRCA analysis. The patient did not have pre-test genetic counseling, so the policy's counseling requirement is not met.",81162,"The patient requested BRCA1 and BRCA2 testing; the policy indicates that when BRCA1/2 sequencing and deletion/duplication analysis will be performed concurrently, CPT code 81162 ('BRCA1/2 full sequencing and duplication/deletion analysis (combined)') is likely most appropriate.",No,"Per the policy, BRCA testing requires meeting clinical indications and pre-test genetic counseling. The patient does not meet the policy's specified personal/family-history clinical criteria and did not receive required pre-test counseling; therefore testing is not covered under the provided BRCA policy.",10247,2376,12623
Case7447,rag,all_incorrect,iter1,WGS,Patient clinical info states the cardiologist ordered whole genome sequencing (WGS) for the fetus.,Yes,"Policy includes fetal indications for genome-wide testing (Section II.2 addresses a fetus with ultrasound anomalies). The patient is a fetus (33 weeks gestation), so the age/gestational status meets the policy's fetal/age category for prenatal sequencing.",No,"Policy (II.2.a) requires pre-test counseling provided by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor for fetal WES/WGS pathways. The ordering clinician is a cardiologist and there is no documentation of the required genetics pre-test counseling, so ordering/provider requirements are not satisfied.",No,"Policy (II.2) requires multiple criteria for fetal sequencing (pre-test genetic counseling, prior CMA and karyotype nondiagnostic, genomic etiology most likely, no other causes, and no well-described syndrome amenable to targeted testing). The record documents an isolated severe congenital heart defect but does not document that CMA/karyotype were nondiagnostic or that other required criteria (including counseling) are met, so the medical indication criteria per policy are not met for WGS.",No,Policy (II.2.b) requires that standard chromosomal microarray (CMA) and karyotype have failed to yield a definitive diagnosis before fetal sequencing. Patient data do not indicate CMA or karyotype have been performed or were nondiagnostic; only fragile X testing (nondiagnostic) is noted.,Not Specified,"Policy includes some family-history scenarios for prenatal sequencing (e.g., recurrent undiagnosed affected fetuses) but the maternal aunt's history of triple-negative breast cancer is not one of the family-history criteria specified as relevant for fetal WES/WGS in Section II.2; the policy does not identify this family history as relevant to coverage for fetal WGS.",No,"Policy (II.2.a and related guidelines) explicitly requires pre-test counseling by an ABMGG geneticist or ABGC genetic counselor for fetal sequencing. There is no documentation of pre-test genetic counseling for this patient, so the counseling requirement is not met.",81425,The requested test is whole genome sequencing (WGS). The CPT code most consistent with clinical WGS among the provided options is 81425 (whole genome sequencing).,No,"Policy states WGS only MEETS COVERAGE CRITERIA when WES was performed and unable to identify a causative mutation and all relevant criteria (including prenatal-specific criteria in II.2, e.g., pre-test genetics counseling and prior nondiagnostic CMA/karyotype) are met (II.4, II.2). In this case, there is no documentation that required prior testing (WES, CMA/karyotype) or required pre-test genetic counseling occurred, therefore WGS is not covered per policy.",22459,2612,25071
Case16126,rag,all_incorrect,iter1,BRCA1/2,Patient information states BRCA1 and BRCA2 testing has been ordered. Basis: patient clinical info.,Not Specified,The provided policy (FEP 2.04.93) does not state age-based eligibility criteria for BRCA1/2 testing or cancer susceptibility testing; patient is a 6-week-old infant but no age rules are specified in the policy text.,Not Specified,The policy discusses genetic counseling and expert performance but does not specify required ordering provider specialty or type for BRCA1/2 testing; the ordering provider being a gynecologist is not addressed as a restriction in the provided policy.,No,"Policy coverage is tied to individuals with a personal and/or family history suggesting an inherited cancer syndrome. The infant has multiple congenital anomalies but no documented personal or family history of breast/ovarian cancer in the provided facts, so the medical indication in the policy is not met.",Not Specified,"The policy does not define specific required prior tests before BRCA1/2 testing; although FISH was nondiagnostic per patient facts, the policy does not require specific prior testing.",No,"The policy specifies family history of cancer as relevant to eligibility; the provided patient information does not document a family history of breast/ovarian cancer (only consanguinity is noted), so the family-history criterion in the policy is not met.",Yes,"The policy states formal genetic counseling is recommended and 'should be performed by an individual with experience and expertise.' The patient had pre-test counseling and plans post-test follow-up with a genetic counselor, meeting the policy's counseling recommendation.",Not Specified,"The provided policy text does not list or map CPT codes for BRCA1/2 or other genetic tests, so a specific CPT from the provided options cannot be determined from the policy.",No,"Based on the FEP policy, cancer susceptibility testing (including panels) is considered only when coverage criteria (personal/family history suggesting inherited cancer syndrome or other related policy criteria) are met. The infant lacks a personal or documented family history of breast/ovarian cancer in the provided facts; therefore BRCA1/2 testing as ordered is not supported by the policy criteria and is not covered.",7671,2033,9704
Case4512,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,Not Specified,"The Humana cardiac genetic policy lists age criteria for specific conditions (eg, FH LDL thresholds) but does not specify any age-based eligibility for WGS; no WGS age criteria are provided in the policy.",Not Specified,The policy does not specify provider specialty or ordering provider requirements for WGS. Appendix lists qualified professionals for genetic counseling but not ordering-provider requirements for whole genome sequencing.,No,"Policy defines medical indications for specific cardiac genetic tests (eg, CPVT, FH, HCM, LQTS). The patient’s diagnosis (major congenital cardiac anomaly since birth) and family history do not match any disease-specific covered indications listed in the policy.",Not Specified,"The policy specifies prior-test requirements for certain listed conditions (eg, LDL measurements for FH, ECG for LQTS) but does not define required prior testing for WGS; no required prior tests for WGS are given.",Not Specified,"The policy specifies family-history criteria for certain covered tests (eg, affected first-degree relative with known pathogenic variant), but it does not specify family-history criteria applicable to WGS; the patient’s sibling history does not meet any specific familial-variant criteria in the policy.",Not Answerable,"Policy requires pre- and post-test genetic counseling by qualified personnel (eg, board-certified/-eligible genetic counselor not employed by a commercial lab). The record states pre-test counseling was done by 'a genetic counselor' but provides no credentialing or employment details to confirm policy compliance.",81425,"Among the provided CPT choices, 81425 corresponds to whole genome sequencing (WGS) genomic analysis; this best matches the WGS requested.",No,The Humana policy limits coverage to specific listed cardiac genetic tests/genes and states members may NOT be eligible for tests other than those listed. WGS is not listed as a covered test and therefore is not covered per the policy.,12150,2562,14712
Case1778,rag,all_incorrect,iter1,WES,Patient information states whole exome sequencing (WES) has been requested for diagnostic clarification of an ocular coloboma.,Yes,"Policy specifies WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a 14-year-old child, which meets the age-related scope in the policy.",Not Answerable,"Policy requires the individual be evaluated by a clinician with expertise in clinical genetics and counseled (Policy Statement #1). The patient record only notes referral by a PCP and request for WES; it does not document a genetics evaluation or counseling, so provider requirement compliance cannot be determined from the supplied information.",Yes,"Policy medical indication includes unexplained congenital anomalies in children as an indication for WES, and the Policy Guidelines list 'coloboma' as an example of a malformation highly suggestive of a genetic etiology; the patient has an ocular coloboma.",Yes,"Policy criterion requires previous genetic testing failed to yield a diagnosis (eg, CMA and/or targeted testing) as part of eligibility. The patient had prior fluorescence in situ hybridization testing that was nondiagnostic, which meets the 'previous genetic testing failed to yield a diagnosis' clause.",No,"The policy lists family history examples as relevant, but the provided patient information includes no family history or consanguinity; therefore no relevant family history is documented.",Not Answerable,"Policy explicitly requires genetic counseling by an individual experienced in genetic medicine (Policy Statement #1 and 'Genetic Counseling' section). The patient data do not state whether counseling occurred, so compliance cannot be determined.",81415,"Of the listed CPT options, 81415 corresponds to clinical exome (whole exome) sequencing and best matches the requested WES.",No,"Although the patient meets age and clinical-indication criteria (unexplained congenital anomaly/coloboma) and prior genetic testing was nondiagnostic, the policy requires ALL criteria be met including documentation of evaluation by a clinician with expertise in clinical genetics and genetic counseling and demonstration of potential for change in management. Those required elements are not documented in the provided information, so coverage cannot be confirmed under the policy.",14788,2665,17453
Case14155,rag,all_incorrect,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been requested by neurology.,Yes,"Policy eligibility is for 'children' with unexplained neurodevelopmental disorders; the patient is a 7-year-old child, meeting the age-group referenced in the policy statement and ACMG guidance cited in the policy.",No,"Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics and counseling. The referral is from neurology with no documented genetics evaluation and pre-test genetic counseling was declined, so ordering/provider requirements are not met.",Yes,"The patient has an unexplained neurodevelopmental disorder (autism spectrum disorder), which is an indication listed in the policy for use of genomic sequencing in children.",No,"Policy criterion #3 expects prior genetic testing (eg, CMA and/or targeted single-gene testing) to have been performed and unrevealing or other specified circumstances; the patient has had no prior genetic testing.",Yes,"The policy lists relevant family history (eg, inborn error of metabolism or genetic disease) as pertinent; the patient has a maternal uncle with a severe immunologic disorder suggesting a family history potentially relevant to genetic evaluation.",No,"Policy criterion #1 requires counseling about potential risks of genetic testing by a genetics-experienced clinician; the family declined pre-test genetic counseling, so the counseling requirement is not met.",Not Specified,The provided policy document does not specify CPT or billing codes for WGS or WES mapping to the listed CPT options.,No,"Although the patient has a qualifying neurodevelopmental indication and is in the pediatric age group, the requested test is WGS and policy distinguishes WES as medically necessary when ALL criteria are met; WGS is described as investigational in other situations and, critically, the patient does not meet required criteria (no genetics evaluation/counseling and no prior genetic testing). Based on the policy statements, coverage is not met.",14842,2678,17520
Case13406,rag,all_incorrect,iter1,WGS,Patient information explicitly states 'Whole genome sequencing (WGS) has been ordered' by a medical geneticist.,Yes,"Policy requires member <21 years of age for genome sequencing; the patient is 6 weeks old, which meets the <21 years age criterion (policy: 'Member is <21 years of age').",Not Specified,"The guideline requires appropriate genetic/family history evaluation and documentation and that the rendering laboratory be qualified, but it does not explicitly mandate a specific ordering provider specialty; thus provider specialty requirements are not specified in the policy.",No,"Policy lists specific clinical indications (e.g., GDD 'following formal assessment by a developmental pediatrician or neurologist'). Patient has concern for global developmental delay but no documentation of a formal assessment by a developmental pediatrician or neurologist, so the specified medical indication is not met per policy.",No,"Policy requires that prior exome/genome not have been performed (met) and that a clinical letter detail prior tests and results. Although CMA was performed and nondiagnostic, there is no documentation provided of the required clinical letter/complete prior-test documentation specified by the guideline.",Yes,"The policy includes family history as a relevant criterion (e.g., 'family history strongly suggestive of a genetic etiology' in rapid WGS criteria). The patient has a sibling history of an unexplained event (altered responsiveness with cyanosis/pallor/irregular breathing), so a relevant family history is present.",Yes,"Policy and ACMG guidance require pretest counseling. Patient information states pre-test counseling has been completed, satisfying the counseling requirement specified in the policy.",81425,Policy specifies 81425 for proband whole genome (WGS) sequence analysis ('81425 should be billed for the proband' for entire genome sequence).,No,"Although age, absence of prior exome/genome, prior nondiagnostic CMA, and pre-test counseling are present, the policy requires documented formal evaluation (e.g., formal developmental assessment by a developmental pediatrician or neurologist for GDD) and a clinical letter detailing differential diagnoses, testing algorithm, prior tests/results, assertion that a genetic etiology is most likely and that GS is most appropriate. Those required documentation elements are not provided in the patient information, so the policy criteria are not fully met and the test is not covered per the guideline.",9176,2638,11814
Case3581,rag,all_incorrect,iter1,BRCA1/2,The clinical information states BRCA1 and BRCA2 testing was ordered.,Not Specified,The Cigna hereditary cancer panel guideline does not state age-based eligibility for BRCA1/2 testing in this document; no age criterion for BRCA testing is specified here.,Not Specified,"The guideline requires pre- and post-test genetic counseling by an appropriate provider but does not define specific ordering-provider specialty requirements for BRCA testing in this document, so ordering-provider requirements are not specified.",No,"Per the guideline, multi-syndrome hereditary cancer testing requires meeting specific clinical criteria (e.g., personal cancer diagnosis consistent with the syndrome or meeting BRCA Analysis criteria). The patient has no personal history of cancer and the record does not document that the patient meets the referenced EviCore BRCA Analysis criteria; therefore medical-necessity criteria are not met.",Not Specified,This guideline addresses multigene panels and refers to test-specific policies for single-gene requests. It does not specify required prior diagnostic tests for single-gene BRCA1/2 testing in this document.,No,The policy uses family history of relevant cancers as part of eligibility. The patient’s family history (a sibling with a brief resolved unexplained event) is not a cancer history and thus does not meet the family-history criteria specified for hereditary cancer testing.,No,"The guideline explicitly requires pre- and post-test genetic counseling by an appropriate provider for hereditary cancer panel testing. The patient had no pre-test genetic counseling, so the counseling requirement is not met.",Not Specified,"The policy lists BRCA-related proprietary/U-codes (e.g., BRCAplus 0129U) and panel codes (e.g., 81432) but does not map the requested single-gene BRCA1/2 test to any of the listed CPT options provided. Of the options given, only 81228 is listed in the document for CMA (not BRCA), so no provided CPT code matches the requested BRCA1/2 test in this policy.",No,"Based on the policy, coverage requires meeting specific hereditary cancer/BRCA clinical criteria and pre-test counseling. The patient has no personal cancer history, does not meet documented BRCA criteria in this record, and has not had pre-test genetic counseling; therefore the request does not meet the policy's medical necessity and counseling requirements and is not covered.",11890,2966,14856
Case10529,rag,all_incorrect,iter1,WES,Patient info explicitly states whole exome sequencing (WES) is being pursued.,Yes,Policy specifies WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a 6-year-old child and therefore meets the age-based child criterion.,Not Answerable,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics. Patient info notes referral by neurology and genetic counseling occurred, but does not explicitly document evaluation by a clinician with expertise in clinical genetics (eg, clinical geneticist) or identify the ordering provider type.",Yes,"Policy defines indication as unexplained neurodevelopmental disorders in children; the patient has nonsyndromic developmental delay and intellectual disability, which is a policy-defined indication for WES.",No,Policy examples of prior testing include chromosomal microarray analysis and/or targeted single-gene testing as part of the prior workup. Patient information documents only Fragile X testing (nondiagnostic); there is no documentation of CMA or other targeted testing required by the policy.,Yes,"Policy lists relevant family history (eg, developmental delay, genetic disease). Patient has a maternal uncle with neurologic disease (dystonia and ataxia), which is relevant family history per the policy.",Yes,"Policy requires genetic counseling; patient/family have seen a genetic counselor multiple times and pre-test counseling is complete with plans for post-test follow-up, meeting the counseling requirement.",81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to clinical exome sequencing and is the best match among the provided CPT options.,No,"Although the patient is a child with an unexplained neurodevelopmental disorder (policy indication) and genetic counseling is documented, the policy requires ALL criteria including documented evaluation by a clinician with expertise in clinical genetics and prior genetic testing (eg, CMA and/or targeted testing) or failure of prior testing with invasive next steps. The record does not document evaluation by a clinical genetics clinician nor prior CMA/targeted testing, so policy-required documentation is incomplete and coverage criteria are not fully met.",14840,2718,17558
Case18821,rag,all_incorrect,iter1,WES,Patient info: obstetrician requests fetal whole exome sequencing (WES) at 22 weeks — request explicitly for WES.,Not Specified,Policy criteria for standard exome sequencing allow testing for 'multiple congenital abnormalities affecting unrelated organ systems' without an explicit prenatal/fetal age limit; the policy does specify age limits for rapid testing of acutely-ill infants but does not set an explicit age requirement for prenatal WES in the Standard Exome section.,No,"Policy requires evaluation by a Board-Certified/Board-Eligible Medical Geneticist or Advanced Practice Nurse in Genetics and pre-/post-test counseling by an appropriate provider (Standard ES, items F and G). Patient info documents ordering obstetrician only and no geneticist/APGN evaluation or documented counseling, so ordering/provider requirements are not met.",Yes,"Policy Standard Exome Sequencing I.A.2.a explicitly lists 'Multiple congenital abnormalities affecting unrelated organ systems' as an indication; patient has prenatal imaging showing multiple congenital anomalies affecting different organ systems, meeting this clinical criterion.",Not Specified,"Policy requires that alternate etiologies be considered and ruled out 'when possible' but does not mandate completion of a specific prior genetic test (e.g., CMA) as an absolute prerequisite in the Standard Exome criteria; thus no specific prior-test requirement is defined.",Yes,"Policy lists 'Family history strongly suggestive of a genetic etiology, including consanguinity' as a supportive criterion. Patient has a maternal aunt reported to have dysmorphic features, which is relevant family history per the policy.",No,"Policy Standard ES item F requires pre- and post-test counseling by an appropriate provider (e.g., Board-Certified Medical Geneticist or Certified Genetic Counselor). Patient information states there is no documentation of pre-test genetic counseling, so the counseling requirement is not met.",81415,Policy coding: Standard Exome Sequencing common CPT code for a proband exome is 81415 (listed in policy's Coverage Criteria/Coding Implications for Standard Exome Sequencing).,No,"Although the patient meets a clinical indication (multiple congenital anomalies) per the policy, mandatory coverage requirements (pre- and post-test genetic counseling and evaluation by a Board-Certified/Board-Eligible Medical Geneticist or APGN per Standard ES items F and G) are not documented. Because required provider/counseling criteria are unmet, the test does not meet all policy coverage conditions.",12240,2145,14385
Case5230,rag,all_incorrect,iter1,WES,Patient clinical information explicitly states whole exome sequencing (WES) was referred/ordered.,Yes,"Policy states WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a 15-year-old child, meeting the age-based scope in the policy.",No,Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics (including family history and phenotype) and counseling; the record shows referral by neurology but no documentation that a clinician with genetics expertise evaluated or counseled the patient.,Yes,"Policy lists unexplained congenital anomalies after standard workup (including nondiagnostic CMA) as an indication; the patient has a congenital anomaly and a nondiagnostic CMA, matching the policy clinical criterion.",Yes,"Policy criteria note WES is indicated when previous genetic testing (eg, chromosomal microarray) has failed to yield a diagnosis; the patient had a nondiagnostic CMA.",Yes,Policy lists family history of an inborn error of metabolism as relevant; the patient has a sibling with an inborn error of metabolism.,No,"Policy requires counseling about potential risks of genetic testing by someone with genetics expertise; the patient explicitly declined genetic counseling, so the counseling requirement is not met.",Not Specified,The provided policy document does not specify CPT or billing codes for WES; no CPT guidance is given in the policy text.,No,"Coverage requires ALL policy criteria be met (including genetics evaluation and counseling). Although age, clinical indication, prior CMA, and relevant family history are met, the required evaluation/counseling by a clinician with genetics expertise was not documented and counseling was declined, therefore the policy conditions for medical necessity are not fully satisfied.",14806,1932,16738
Case6478,rag,all_incorrect,iter1,BRCA1/2,Patient information explicitly states referral for germline BRCA1 and BRCA2 testing; policy covers BRCA1/BRCA2.,Yes,Policy prohibits routine testing in minors but includes testing 'at any age' for metastatic prostate cancer; patient is 52 (adult) and therefore meets age-related criteria.,No,"Policy requires testing to be performed in a setting with suitably trained providers who can give appropriate pre- and post-test counseling. The ordering provider is a general practitioner and pre-test genetic counseling was not completed, so provider/setting requirements are not satisfied per policy.",Yes,"Policy lists 'personal history of metastatic ... prostate cancer at any age' and/or a close relative with pancreatic cancer as indications; the patient has metastatic prostate cancer and a father with pancreatic cancer, meeting medical criteria.",Not Specified,Policy does not mandate prior diagnostic testing for an affected individual in this scenario; it recommends affected-relative testing in some situations but does not require prior tests for a patient with metastatic prostate cancer.,Yes,"Policy specifies close blood relatives (1st-3rd degree) with pancreatic cancer as relevant criteria; the patient’s father had pancreatic cancer (1st-degree), which is relevant.",No,"Policy states genetic testing should be preceded by appropriate pre-test counseling by qualified personnel; the patient did not complete pre-test counseling (only plans post-test counseling), so counseling requirements are not met.",Not Specified,The provided policy document does not list or map specific CPT codes to BRCA1/2 testing; therefore a CPT code cannot be determined from the policy text alone.,No,"Although the patient meets medical indications and age criteria for germline BRCA1/2 testing (metastatic prostate cancer and a first-degree relative with pancreatic cancer), the policy requires testing to be performed in a setting with suitably trained providers and appropriate pre-test genetic counseling. Pre-test counseling was not completed and the ordering situation does not satisfy the counseling/provider requirement in the policy, so coverage is not supported as presented.",18940,2441,21381
Case13613,rag,all_incorrect,iter1,WES,Patient information states the pregnancy was referred for whole exome sequencing (WES) to assess fetal anomalies; the requested test is explicitly WES.,No,Policy medical-necessity statements and criteria apply to children (and critically ill infants) and the Policy Guidelines explicitly state the policy does not address prenatal (fetal) testing; the patient is a fetus and therefore does not meet the age-related/setting criteria in the policy.,Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling prior to WES. Patient had pre-test discussion with a genetic specialist, satisfying the provider/counseling requirement.",Yes,"Policy lists 'multiple congenital anomalies' as a medical indication for WES. The fetus has multiple structural anomalies on imaging, meeting the clinical indication criterion (regardless of prenatal exclusion).",No,"Policy criteria require prior standard workup (eg, chromosomal microarray analysis and/or targeted single-gene testing) or prior genetic testing that failed to yield diagnosis. Patient only had fragile X testing (nondiagnostic); no CMA or equivalent prior testing documented.",Yes,"Policy guidance emphasizes documentation of family history; patient has a relevant family history (maternal aunt with dysmorphic features), meeting the family-history criterion.",Yes,"Policy requires counseling by someone with expertise in genetic medicine; patient had pre-test discussion with a genetic specialist, meeting the counseling requirement.",81415,"The requested test is whole exome sequencing (WES); among the provided CPT options, 81415 corresponds to clinical exome/exome sequencing and is the best match for WES.",No,"From an adjudication perspective, the policy explicitly states it does not address prenatal (fetal) testing and limits medically necessary WES indications to children/critically ill infants per policy statements; prenatal WES is therefore not supported as a covered indication under this policy.",14831,1964,16795
Case5380,rag,all_incorrect,iter1,WGS,Patient record explicitly states 'whole genome sequencing (WGS) is requested.' (Patient information).,Yes,"Policy specifies age-based applicability: onset of seizures in early childhood (before age 5) (Policy Guidelines). Patient is an 8-week-old infant, which meets the <5 years criterion.",Not Specified,The epilepsy policy does not specify a required ordering provider specialty or credential for genetic testing; it only states genetic counseling should be performed by an experienced individual (Genetic Counseling section).,No,"Policy Guidelines define medical necessity requiring: (1) onset <5 yrs AND (2) clinically severe seizures affecting daily functioning and/or interictal EEG abnormalities AND (3) no other clinical syndrome better explaining symptoms. Patient meets onset criterion but the record lacks documentation of clinically severe seizures affecting daily functioning or documented interictal EEG abnormalities and does not state that no other syndrome explains symptoms, so the defined clinical criteria are not met.",Not Specified,"The policy does not state that specific prior tests (e.g., CMA or targeted panel) are required before WGS; it references testing strategies and cross-references MP 2.324 for WES/WGS criteria but does not mandate prior testing in this document.",Not Specified,The policy does not set family history or consanguinity as explicit eligibility criteria for genetic testing for epilepsy. The patient’s maternal short stature is noted but the policy does not tie this to eligibility.,No,"Policy states formal genetic counseling should be performed by someone experienced and experts recommend counseling in most cases (Genetic Counseling section). The family declined pre-test genetic counseling, so the patient does not meet the policy's stated counseling expectation.",81425,"Among the provided CPT options, 81425 corresponds to whole genome sequencing (81415 corresponds to whole exome sequencing). The test requested is WGS, so 81425 is the best match.",No,"Per the policy, medically necessary testing requires defined clinical criteria (onset <5 yrs, clinically severe seizures affecting daily functioning and/or interictal EEG abnormalities, and no other syndrome better explaining symptoms). Although the patient’s age meets the criterion, documentation does not demonstrate clinically severe seizures or EEG findings, and the family declined the recommended pre-test genetic counseling. Based on the policy's medical necessity and counseling requirements, coverage is not supported.",16916,2442,19358
Case15570,rag,all_incorrect,iter1,BRCA1/2,Patient clinical note: clinician requested BRCA1 and BRCA2 testing for the 15-year-old. This explicitly names BRCA1/2 as the ordered test.,Not Specified,The provided FEP policy (2.04.126) discusses testing for CHEK2/ATM/BARD1 and references related BRCA policy but does not specify age-based eligibility criteria for BRCA1/2 in the text supplied.,Not Specified,The provided policy emphasizes that genetic counseling should be performed by individuals experienced in genetic medicine but does not specify ordering-provider specialty or type requirements for BRCA1/2 in the supplied text.,Not Specified,"The supplied policy text does not provide explicit medical-indication criteria for BRCA1/2 testing (BRCA criteria are in a related policy referenced but not included), so no specific clinical criteria for BRCA testing are defined in the provided document.",Not Specified,"The supplied policy does not define required prior testing specifically for BRCA1/2 (it notes testing an affected family member first is preferred in general NCCN guidance, but no explicit prior-test requirements for BRCA in the provided text).",No,"Policy references family history as important for hereditary breast/ovarian cancer risk assessment. The patient has no documented family history of cancer (mother has bipolar disorder only), so the patient does not have the family-history criteria relevant to hereditary breast cancer testing.",No,"The policy states formal genetic counseling is recommended/important prior to inherited-condition testing. The patient has no documentation of pre-test genetic counseling, so counseling requirements are not met.",Not Specified,The provided policy text does not list or map CPT codes to BRCA1/2 testing; therefore a specific CPT code cannot be determined from the supplied document.,No,"Under the provided policy framework, benefits are available only when testing is medically necessary for diagnosis/management and testing is guided by hereditary breast/ovarian cancer risk criteria (e.g., NCCN). The patient is a 15-year-old with Hirschsprung disease, no personal or family history of cancer, and no documented pre-test genetic counseling; the request appears unrelated to a covered medical indication. Based on the supplied policy language, the BRCA1/2 test is not supported as medically necessary for this patient and is therefore not covered.",11010,2506,13516
Case5834,rag,all_incorrect,iter1,CMA,Patient clinical information explicitly states the test being requested is chromosomal microarray (CMA). (Patient data),Not Specified,The provided FEP WES/WGS policy specifies age criteria for WES/WGS (children) but does not state any age-based eligibility criteria for chromosomal microarray (CMA). (Policy: no CMA age criteria),Not Specified,"The WES/WGS policy includes ordering requirements for WES/WGS (eg, evaluation by genetics) but does not specify ordering-provider requirements for CMA. (Policy: no CMA provider requirements)",Not Specified,The policy defines medical indications for WES/WGS (children with unexplained congenital or neurodevelopmental disorders) but does not define specific medical indication criteria for CMA. (Policy: CMA not addressed),Not Specified,"The policy lists prior testing expectations as part of WES/WGS criteria (eg, CMA may be prior testing) but does not specify required prior tests before performing CMA itself. (Policy: no CMA prior-test requirements)",Not Specified,"The WES/WGS policy includes family-history criteria relevant to WES/WGS, but the policy does not specify family history or consanguinity criteria for CMA; the patient's reported family history (mother with ovarian cancer) is not identified in the policy as relevant to CMA. (Policy: no CMA family-history criteria)",Not Specified,The policy requires genetic counseling documentation for WES/WGS but does not state counseling requirements specific to CMA. (Patient fact: counseling completed; Policy: no CMA counseling requirement specified),Not Specified,The provided policy document does not list or map CPT codes to chromosomal microarray (CMA); none of the CPT options are specified in the policy. (Policy: CPT codes not provided),Yes,Under 'Benefit Application' the policy states benefits are available for specialized diagnostic genetic testing when medically necessary to diagnose/manage a patient's existing medical condition. The patient has an existing developmental/intellectual disability and CMA is being ordered to evaluate a genomic etiology; pre-test counseling completed. The policy does not exclude CMA and permits coverage of medically necessary diagnostic genetic testing. (Policy: Benefit Application + patient facts),14855,2541,17396
Case1501,rag,all_incorrect,iter1,WES,Patient info explicitly states Whole Exome Sequencing (WES) is being ordered.,Yes,Policy states predictive genetic testing in related children for inherited arrhythmia syndromes (including LQTS/CPVT/BrS) is recommended from birth onward; the patient is age 2 so meets age-based criteria relevant to the family-history LQTS indication (policy coverage rationale and EHRA/HRS guidance).,Not Specified,The policy does not specify ordering-provider specialty/type requirements for genetic testing; it only states pre-test genetic counseling is strongly recommended.,Not Specified,"The policy defines medical indications for targeted multi-gene cardiac panels (e.g., family history of congenital LQTS) but does not explicitly define diagnostic/coverage indications for WES as the requested test; WES-specific indications are not specified in the policy.",Not Specified,"The policy specifies some prior/phenotypic testing requirements for certain cardiac diagnoses (e.g., ECG/Schwartz score for LQTS) but does not define a universal required prior-test sequence for WES; no explicit prior-test requirement for WES is provided.",Yes,Patient has a first-degree relative (mother) with Long QT syndrome; the policy lists multi-gene panel testing as medically necessary for asymptomatic individuals with a first- or second-degree relative with congenital LQTS (Testing Based Only On Family History).,Not Specified,"The policy states that pre-test genetic counseling is 'strongly recommended' but does not state it as an absolute coverage requirement; the patient did receive pre-test counseling, but the policy does not make counseling a strict coverage condition.",81415,The patient is requesting Whole Exome Sequencing (WES); CPT code 81415 corresponds to exome sequencing and is the best match for WES per coding conventions referenced in the policy context (policy describes exome/genome technologies).,No,"Although the patient has a relevant family history of congenital LQTS (which the policy supports for targeted multi-gene panel testing), the policy coverage rationale is written around targeted multi-gene panels (and microarray profiles) for cardiac syndromes. WES is not explicitly listed as a covered/medically necessary modality for this indication in the policy text; therefore the requested WES is not supported as covered under this policy.",39565,3081,42646
Case10427,rag,all_incorrect,iter1,WGS,Patient information states whole genome sequencing (WGS) is being requested.,Yes,Policy M2032 ties pediatric genomic testing to the <18 y indication for WES and the WGS coverage pathway depends on those criteria; the patient is an 8‑week‑old infant (<18 years) so age requirement for the pediatric pathway is met.,Not Answerable,"Policy requires evaluation by an ABMGG board‑certified medical geneticist or an ABGC board‑certified genetic counselor; the chart only notes 'genetic counselor' without board‑certification or ABMGG evaluation details, so sufficiency cannot be confirmed from provided information.",Yes,"Policy indicates WES/WGS applicability for unexplained congenital or neurodevelopmental disorders in <18 y; the infant has significant unexplained hypotonia and family history suggesting a genomic etiology, which meets the clinical indication described in the policy.",No,"Policy states WGS MEETS COVERAGE CRITERIA only when WES was performed and failed to identify a causative mutation; there is no record of prior WES (only nondiagnostic FISH), so required prior testing has not been completed.",Yes,Patient has a relevant family history (older sibling with unexplained developmental regression); the policy references family history/recurrence as relevant to genomic testing eligibility.,Not Answerable,"Policy requires pretest counseling by an ABMGG medical geneticist or an ABGC board‑certified genetic counselor; the record confirms pretest counseling occurred but does not state the counselor's ABGC board‑certification, so compliance cannot be confirmed from provided data.",Not Specified,"The provided policy document (M2032) does not list or map CPT codes to WGS/WES, so no specific CPT code can be determined from the policy text alone.",No,"Per policy M2032, WGS is covered only when WES has been performed and failed to identify a causative mutation while the other WES criteria are met; since WES has not been documented as performed and the request is for direct WGS, the WGS request does not meet coverage criteria.",22480,3232,25712
Case8485,rag,all_incorrect,iter1,WES,Patient clinical information states whole exome sequencing (WES) has been ordered.,Not Specified,Policy refers to 'children' but does not give a specific numeric age cutoff; no explicit age-based eligibility criterion is specified in the policy text.,No,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled about risks; the ordering provider is a general pediatrician and pre-test genetic counseling was not performed, so provider requirements are not met per policy.",Yes,"Policy defines indications for children with unexplained congenital or neurodevelopmental disorders and lists 'significant hypotonia' and developmental delay as clinical features suggesting a genetic disease; the patient has hypotonia and persistent motor delay, meeting a defined clinical indication.",No,"Policy indicates prior testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) should have been done or failed to yield a diagnosis; the record notes only nondiagnostic Fragile X testing, with no CMA/targeted testing documented, so required prior tests were not completed.",Yes,"Policy lists family history of developmental delay as relevant; the family reports a sibling with autism spectrum disorder, which meets the policy's family history criterion.",No,Policy states genetic counseling should be performed by someone with experience and expertise and is part of the required documentation; pre-test genetic counseling was not performed for this patient.,Not Specified,The provided policy document does not list or map specific CPT codes to WES; no CPT guidance is given in the policy text.,No,"Although the patient meets the clinical indication (neurodevelopmental disorder with hypotonia and family history), the policy requires ALL criteria (including evaluation by a clinician with genetics expertise and genetic counseling, and appropriate prior testing) to be met for WES to be medically necessary; those documentation requirements and prior testing were not met, so coverage is not supported per the policy.",14824,1461,16285
Case11795,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being ordered after nondiagnostic CMA.,Not Specified,The provided policy (FEP 2.04.59) discusses CMA and NGS panels and does not state age-based eligibility criteria for whole exome sequencing; WES is addressed in a separate policy (2.04.102) not provided.,Not Specified,The policy discusses genetic counseling and that testing should be by experienced providers but does not specify ordering-provider specialty or explicit ordering requirements for WES.,Not Specified,"The policy defines indications for CMA and states NGS panels are investigational for developmental delay/ID/ASD, but it does not define clinical indications or medical necessity criteria for WES (addressed in a separate policy not provided).",Not Specified,"The policy discusses CMA as first-tier for developmental delay/ID/ASD and notes tiered testing, but it does not specify required prior testing for WES; patient has had CMA nondiagnostic (fact), but the policy does not state that CMA completion is a prerequisite for WES.",Not Specified,"While the patient has a sibling with intellectual disability (family history), the provided policy does not specify family history or consanguinity criteria relevant to WES eligibility in this document.",Yes,"Policy states genetic counseling is recommended/should be performed by qualified individuals. Patient had pre-test genetic counseling with plans for post-test follow-up, meeting the policy's counseling expectations.",81415,The requested test is whole exome sequencing; CPT code 81415 corresponds to exome (whole exome) sequence analysis and is the best match among provided codes.,No,"The provided policy addresses CMA (medically necessary for developmental delay/ID/ASD) and labels NGS panels investigational for those indications; WES coverage is not addressed in this policy (it is referenced as handled by a separate policy 2.04.102 which is not provided). Because no coverage criteria for WES are present in the supplied policy document and NGS testing is treated as investigational in related contexts, coverage cannot be established from the provided policy text; therefore, based solely on the provided documentation, the test is not supported as covered.",15734,2039,17773
Case2007,rag,all_incorrect,iter1,BRCA1/2,Patient clinical information explicitly states referral for BRCA1 and BRCA2 testing; policy text references BRCA1/2 in related guidelines (ASBS/ASCO) but the requested test in the clinical information is BRCA1/2.,Not Specified,The provided FEP policy (2.04.126) discusses CHEK2/ATM/BARD1 and references related policy 2.04.02 for BRCA1/2 but does not specify age-based eligibility criteria for BRCA1/2 within the provided text.,Not Specified,The provided policy recommends genetic counseling by experienced providers but does not specify ordering-provider specialty or strict provider-type requirements for BRCA1/2 testing in the included text.,Yes,"Policy text (American Society of Breast Surgeons guidance cited in the document) states genetic testing should be made available to all individuals with a personal history of breast cancer and should include BRCA1/BRCA2; the patient has a personal history of metastatic breast cancer, so meets this clinical indication.",Not Specified,"The provided policy does not state specific prior-test requirements before BRCA1/2 testing. The patient had a nondiagnostic CMA, but the policy does not require CMA or other prior tests before BRCA1/2 testing in the included text.",Yes,"The policy discusses family history as relevant to genetic risk evaluation (NCCN/ASBS statements). The patient reports a mother with breast cancer at age 50 or younger, which is a relevant family history per the policy.",Yes,"Policy guidelines state genetic counseling should be performed by an individual with experience in genetic medicine; the patient completed pre-test counseling and will return for post-test counseling, meeting the counseling recommendation in the policy.",Not Specified,The provided policy text does not list or map specific CPT codes to BRCA1/2 or other tests; therefore a specific CPT code cannot be determined from the policy document alone.,Yes,"Basis: Benefit application in the policy permits coverage for specialized diagnostic genetic testing that is medically necessary, and cited professional guidance (American Society of Breast Surgeons and ASCO references in the policy) states genetic testing including BRCA1/2 should be available to individuals with a personal history of breast cancer. The patient has metastatic breast cancer and relevant family history and has completed pre-test counseling, supporting coverage under the policy as medically necessary.",11011,2262,13273
Case7297,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued to identify an underlying genetic etiology.,Yes,"Policy states WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a 3-year-old child, which meets the 'children' age criterion in the policy.",Yes,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling; patient had pre-test counseling completed with a genetic specialist, satisfying the provider/evaluation requirement.",Yes,"Policy medical indication includes children with multiple unexplained congenital anomalies; the patient has multiple congenital anomalies affecting different organ systems, meeting the specified clinical indication.",Yes,"Policy requires that a genetic etiology be considered despite previous genetic testing or when prior testing failed to yield a diagnosis; the patient had prior karyotype testing that was nondiagnostic, which fulfills the 'previous testing failed' criterion.",Not Specified,"Policy discusses family history examples relevant for selection (eg, arrhythmia, developmental delay) and requires documentation of family history, but it does not specifically list maternal aunt with ovarian cancer as a defined eligibility criterion for WES; thus specific relevance is not specified in the policy.",Yes,"Policy requires genetic counseling by an individual experienced in genetic medicine; patient had pre-test counseling with a genetic specialist and plans for post-test follow-up, meeting the counseling requirement in the policy.",81415,The requested test is whole exome sequencing; CPT code 81415 corresponds to exome sequencing and is the best match among the provided code options.,Yes,"All policy-required criteria are met: patient is a child with multiple congenital anomalies, has been evaluated/counseled by a genetics specialist, and prior genetic testing (karyotype) was nondiagnostic; under the policy, standard WES may be considered medically necessary in this scenario.",14850,2413,17263
Case2666,rag,all_incorrect,iter1,BRCA1/2,Patient information explicitly states she 'is undergoing BRCA1/2 testing at the request of her obstetrician.',Not Specified,The provided FEP policy document is specific to CHEK2/ATM/BARD1 and references a related BRCA1/2 policy (2.04.02) but the BRCA1/2 policy text and any age-based eligibility criteria are not included in the provided documents.,Not Specified,The provided policy does not specify ordering-provider specialty or other formal ordering requirements for BRCA1/2 testing; genetic counseling is recommended but no explicit ordering-provider requirement for BRCA1/2 is given in the supplied text.,Not Specified,The supplied policy focuses on CHEK2/ATM/BARD1 and does not contain the BRCA1/2 coverage criteria or specific medical indications (those would be in related policy 2.04.02 which was not provided).,Not Specified,The provided policy does not state any prerequisite testing specifically required prior to BRCA1/2 testing; related guidance (BRCA1/2 policy) is not included in the supplied documents.,Not Specified,"Although the patient has a relevant family history (father with metastatic prostate cancer) and the policy emphasizes consideration of personal/family history, the provided document does not specify BRCA1/2-specific family-history criteria, so applicability cannot be determined from the supplied text alone.",Yes,"The provided policy's 'Genetic Counseling' section states formal genetic counseling is recommended when genetic testing for an inherited condition is considered and should be performed by an experienced provider; the patient completed pre-test counseling with a genetic specialist and has plans for post-test follow-up, meeting the counseling recommendation in the supplied policy.",Not Specified,The provided policy document does not list or map CPT codes to BRCA1/2 testing; no CPT-code assignment is specified in the supplied text.,No,"The only FEP policy text provided addresses CHEK2/ATM/BARD1 (stating those tests are investigational) and references a separate BRCA1/2 policy that was not included. The supplied documents do not provide explicit coverage criteria establishing BRCA1/2 as a covered service for this patient; benefits are stated to be available only when testing is 'medically necessary,' which is not demonstrated by the provided policy text. Therefore, coverage cannot be affirmed based on the provided policy and must be denied.",11011,2786,13797
Case13983,rag,all_incorrect,iter1,WGS,Patient info explicitly states whole genome sequencing (WGS) is being pursued at the request of the ordering gynecologist.,Not Specified,The policy discusses pediatric testing and phenotype-based criteria but does not define explicit age-based eligibility cutoffs for genetic testing; no age restriction for WGS is specified.,No,"Policy Guidelines state 'Genetic testing should be performed by an expert in genetic testing and/or cardiac ion channelopathies.' The ordering provider is a gynecologist, which does not meet the policy-specified expert requirement.",Yes,"Policy allows genetic testing when signs/symptoms of a channelopathy are present but a definitive diagnosis cannot be made without testing. The infant has a high-risk BRUE and a significantly abnormal ECG raising concern for an underlying channelopathy, satisfying a medical indication for testing.",Not Specified,"The policy recommends a comprehensive clinical evaluation (history, physical, ECG, echo, stress testing as indicated) and starting with known familial variant when available, but it does not mandate a specific set of prior tests that must be completed in all cases before genetic testing; the patient has an ECG and nondiagnostic FISH but not all listed evaluations are documented.",No,"Policy criteria for family-history–based testing require a close relative with a known pathogenic channelopathy variant or a clinical diagnosis. The reported maternal uncle has unexplained developmental regression (not described as a channelopathy), so the policy-specified family history criterion is not met.",Yes,"Policy states genetic counseling is recommended/appropriate; the patient had pre-test counseling with a genetic counselor and plans for post-test follow-up, meeting the counseling requirement.",Not Specified,"The provided policy document does not list or map specific CPT codes to whole genome sequencing or other tests, so no CPT code is specified in-policy.",No,"Although the clinical indications (abnormal ECG and suspected channelopathy) meet the policy's medical-necessity criteria for genetic testing, the requested test is WGS (a broad genome test) and the policy emphasizes testing by experts and targeted testing (start with familial variant or targeted/syndrome-focused testing). The ordering provider does not meet the policy-specified 'expert' requirement (Q2 = No), and the policy discourages broad gene panels/testing beyond the indicated channelopathy genes. Based on the policy requirements and the unmet ordering-provider criterion and lack of indication that WGS is an appropriate targeted method in-policy, the request as submitted is not covered.",15953,2335,18288
Case15458,rag,all_incorrect,iter1,BRCA1/2,Patient clinical information explicitly states she is being evaluated for BRCA1 and BRCA2 testing.,Not Specified,The provided policy text (FEP 2.04.126) does not specify age-based eligibility criteria for BRCA1/2 testing; it references BRCA testing policy 2.04.02 but does not provide age limits in the included text.,Not Specified,The policy discusses genetic counseling and provider expertise but does not state specific ordering-provider specialty or licensure requirements for BRCA1/2 testing in the provided text.,Yes,"Patient has a personal history of breast cancer. The included policy text (ASBS guidance cited) states genetic testing should be made available to all individuals with a personal history of breast cancer and should include BRCA1/BRCA2, supporting medical indication.",Not Specified,"The provided policy text does not require completion of specific prior tests (e.g., prior targeted family testing) before BRCA1/2 testing in the excerpt given.",Yes,"The policy emphasizes family history in risk evaluation (NCCN and other guidelines cited). The patient has family history (ovarian cancer in a maternal aunt and a close relative with prostate cancer), which is relevant per the policy.",Yes,"The policy states formal genetic counseling is recommended/should be performed; the patient completed pre-test genetic counseling with plans for post-test follow-up, satisfying the policy's counseling expectations in the provided text.",Not Specified,"The provided policy text does not list or map CPT codes to BRCA1/2 testing, so no specific CPT from the provided options can be selected based on the policy.",Yes,"Based on the provided policy text, BRCA1/2 testing is recommended for individuals with a personal history of breast cancer (ASBS and guideline citations) and benefits are available for specialized diagnostic genetic testing when medically necessary; the patient meets those clinical indications and completed pre-test counseling, so coverage is supported by the provided policy text.",11022,2117,13139
Case18868,rag,all_incorrect,iter1,WGS,Patient information states whole genome sequencing (WGS) was ordered to assess hereditary cancer predisposition.,Not Specified,The policy's Cancer Exome and Genome Sequencing section addresses investigational status but does not specify any age-based eligibility criteria for WGS.,Not Specified,The policy does not state specific ordering provider/specialty requirements for cancer exome/genome sequencing (WGS) in this document.,No,"The policy explicitly states 'Cancer exome and genome sequencing in solid tumors and hematologic malignancies (0036U, 0329U, 81415, 81416, 81425, 81426) is considered investigational.' Therefore the requested WGS does not meet a defined medically necessary indication in this policy.",Not Specified,The policy does not define required prior tests that must be completed before ordering cancer exome/genome sequencing; it only designates the testing as investigational.,Not Specified,"Although the patient has a family history (mother with hematologic disorder), the policy does not specify family history or consanguinity criteria relevant to coverage for cancer exome/genome sequencing (WGS).",Not Specified,"The policy discusses informing patients about potential germline findings and recommends genetic evaluation, but it does not state a specific required pre-test genetic counseling documentation requirement for WGS within this policy.",81425,"The policy lists 81415, 81416, 81425, 81426 among codes for cancer exome/genome sequencing; 81425 is the code included in the policy group corresponding to cancer exome/genome sequencing (mapped to the requested WGS).",No,"Per the policy, 'Cancer exome and genome sequencing ... (0036U, 0329U, 81415, 81416, 81425, 81426) is considered investigational,' therefore the requested WGS is not covered.",32983,1846,34829
Case10917,rag,all_incorrect,iter1,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered to evaluate an underlying genetic cause.,Not Specified,The policy describes WES indications for 'children' and critically ill 'infants' but does not impose a specific numeric age cutoff for standard WES; thus no explicit age-based exclusion applies in the policy.,Yes,"Policy criterion 1 requires evaluation and counseling by a clinician with expertise in clinical genetics. Patient was evaluated by a medical geneticist and had pre-test counseling by a genetic specialist, satisfying ordering/provider requirements.",No,"Policy requires ALL criteria for medically necessary standard WES, including (1) specialist evaluation/counseling (met), (2) potential for change in management (not documented), and (3) genetic etiology most likely despite previous genetic testing OR prior genetic testing failed to yield diagnosis. The record documents only nondiagnostic Fragile X testing; no documentation of prior CMA or targeted testing or documented potential management change, so the policy's required medical-indication criteria are not fully met.",No,"Policy indicates prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or failure of prior testing is part of eligibility for standard WES. Patient record documents only Fragile X testing; no CMA or other targeted testing is reported.",Yes,"Policy Guidelines list family history (eg, developmental delay or congenital anomalies) as relevant. Patient has an older sibling with multiple congenital anomalies, which is relevant to eligibility per the policy.",Yes,"Policy requires genetic counseling by an experienced clinician. The patient had pre-test counseling completed with a genetic specialist, meeting the counseling requirement.",81415,"Of the provided CPT options, 81415 corresponds to clinical whole exome sequencing and best matches the requested WES.",No,"Although provider evaluation, counseling, and relevant family history are documented, the policy requires ALL listed criteria for standard WES be met (including documentation of prior relevant genetic testing or that a genetic etiology is most likely despite prior testing, and documented potential to change management). The record lacks documentation of prior CMA/targeted testing or explicit documentation that these policy-required elements are met, so under the policy the WES request is not covered.",14837,2356,17193
Case12792,rag,all_incorrect,iter1,BRCA1/2,Patient clinical information explicitly states the referral is for BRCA1/2 testing.,Not Specified,The provided FEP policy text does not specify age-based eligibility criteria for BRCA1/2 testing (BRCA testing strategy is referenced to a different policy not provided).,Not Specified,The provided policy does not specify ordering-provider (specialty/type) requirements for BRCA1/2 testing.,Not Specified,The supplied policy text addresses CHEK2/ATM/BARD1 and references BRCA1/2 testing guidance in a separate policy (2.04.02) that is not included; specific medical indications for BRCA1/2 are not defined in the provided document.,Not Specified,The provided policy does not list prerequisite or prior test requirements for BRCA1/2 testing; prior FISH is noted in the patient facts but no policy requirement for prior testing is given.,No,"The policy emphasizes family history as relevant (NCCN criteria and multiple references to family history in the provided text), and the patient’s history includes only a maternal growth abnormality with no reported family history of breast/ovarian cancer—thus the patient does not have the relevant family history per the policy context.",Yes,"The policy states formal genetic counseling is recommended/expected for inherited-condition testing and should be performed by experienced personnel; the patient completed pre-test genetic counseling and post-test follow-up is planned, meeting the policy's counseling expectations.",Not Specified,"The provided policy text does not list or map CPT codes for BRCA1/2 testing, so no CPT code can be determined from the document.",No,"Based solely on the provided policy text: BRCA1/2 coverage criteria are not included in this document, there is no documentation in the provided policy that BRCA testing is medically necessary for a 12‑year‑old with congenital choanal atresia and no relevant family history of breast/ovarian cancer, and benefits apply when testing is medically necessary to diagnose/manage an existing condition—criteria not met here; therefore the test is not covered per the provided policy context.",10994,2721,13715
Case8710,rag,all_incorrect,iter1,WES,Patient information states whole exome sequencing (WES) has been requested.,Yes,"Policy defines pediatrics <21 years as eligible for standard WES/WGS; patient is 12, meeting the age requirement (policy: 'pediatrics under 21 years of age').",No,"Policy requires the individual 'has been evaluated by a clinician with expertise in clinical genetics and counseling was provided.' The patient was referred by a developmental pediatrician and no genetics evaluation or pre-test counseling is documented, so ordering/provider requirements are not met.",Yes,"Policy requires an unexplained neurodevelopmental disorder in a pediatric patient plus one of listed criteria; the patient has autism spectrum disorder with an additional organ-system abnormality and prior karyotype was nondiagnostic, satisfying the 'previous genetic testing is non-diagnostic' medical indication.",Yes,"Policy allows WES when 'previous genetic testing is non-diagnostic.' Patient had prior nondiagnostic karyotype, which meets the 'previous genetic testing non-diagnostic' prior-test criterion in the policy.",Yes,"Patient has a family history of neurologic disease in a paternal uncle (dystonia/ataxia). The policy lists family history of neurologic/genetic disease as a relevant clinical feature for genetic evaluation, so a relevant family history is present.",No,"Policy explicitly requires genetic counseling by an individual with genetic expertise before testing. The record states no pre-test genetic counseling was documented, so counseling requirements are not met.",81415,The policy's coding section lists 81415 among codes covered when medically necessary and 81415 corresponds to exome sequencing (standard WES).,No,"Although age, diagnosis, and prior nondiagnostic genetic testing meet policy clinical criteria, the policy requires evaluation by a clinician with expertise in clinical genetics and documented pre-test genetic counseling as part of ALL criteria for medical necessity; those provider/counseling requirements are not met in the patient information, so WES is not covered per policy.",14874,2369,17243
Case16246,rag,all_incorrect,iter1,BRCA1/2,Patient was referred for BRCA1 and BRCA2 testing (stated explicitly). Policy MOL.TS.238.A addresses germline BRCA analysis.,Yes,"Policy requires age >=18 for full sequence analysis. Patient is 35 years old, which meets the policy age requirement for BRCA testing (Full Sequence Analysis: 'Age 18 years or older').",Not Specified,"Policy requires 'pre- and post-test genetic counseling by an appropriate provider (as deemed by the Health Plan policy)' but does not explicitly restrict which ordering provider specialties may order BRCA testing; the patient’s ordering provider is a gynecologist, and the policy does not specify ordering-provider specialty requirements.",Yes,"Policy lists 'Female with breast cancer diagnosis 50 years of age or younger' as a diagnostic indication for full sequence BRCA testing. Patient had breast cancer before age 50 (age 35), so she meets a defined clinical indication.",Yes,"Full sequence analysis criteria require 'No previous full sequencing of BRCA1/2' and no known family mutation. Patient had prior karyotype testing only (nondiagnostic) and no prior BRCA sequencing or known familial BRCA mutation, so prior-test requirements are satisfied per policy.",Yes,"Policy counts pancreatic cancer in a close blood relative as relevant family history ('Pancreatic cancer in at least 1 close blood relative (first-, second-, or third-degree)'). The patient reports an uncle (second-degree) with pancreatic cancer, which is a relevant family history per policy.",No,"Policy requires pre- and post-test genetic counseling for BRCA testing ('Genetic Counseling: Pre- and post-test genetic counseling...'). The patient has had no pre-test genetic counseling, so the counseling requirement is not met.",81162,"Policy procedure codes include BRCA1/2 full sequencing and deletion/duplication combined as 81162 and states 'If BRCA1/2 deletion/duplication analysis will be performed concurrently with BRCA1/2 gene sequencing, CPT code 81162 is likely most appropriate.' The request is for BRCA1/2 testing and the combined code is the appropriate code when both sequencing and del/dup are performed.",No,"Although the patient meets age, clinical indication (breast cancer <50), and prior-test requirements, the policy explicitly requires pre- and post-test genetic counseling for BRCA testing. The patient has not had pre-test genetic counseling, so a required coverage criterion is unmet and the test is not covered per the policy.",10261,1973,12234
Case14017,rag,all_incorrect,iter1,WES,Patient record explicitly states whole exome sequencing (WES) has been ordered.,Yes,"Policy requires seizure onset in early childhood (before age 5). The patient is 7 weeks old, which meets the policy's age-based criterion.",Not Specified,The policy does not specify restrictive ordering-provider specialty or credential requirements for genetic testing in epilepsy.,No,"The policy's medical-necessity application requires (among other things) 'clinically severe seizures that affect daily functioning and/or interictal EEG abnormalities.' The record documents recurrent seizure-like events/BRUE but does not document clinically severe seizures affecting daily functioning or interictal EEG abnormalities, so the explicit clinical criteria in this policy are not met.",Not Specified,The policy discusses testing strategies (targeted testing or multigene panels; WES criteria in a related policy) but does not specify required prior tests that must be completed before WES in this document.,Not Specified,"Although the patient has a maternal uncle with neurologic disease, the policy does not define family-history or consanguinity criteria as explicit eligibility requirements for genetic testing for epilepsy in this document.",Not Specified,"The policy strongly recommends formal genetic counseling and states it should be performed by experienced personnel, but it does not state counseling is an explicit coverage prerequisite; the record notes pre-test counseling was completed.",81415,The requested test is whole exome sequencing; CPT code 81415 corresponds to exome sequencing (whole exome).,No,"Under the BCBS_FEP policy, genetic testing is medically necessary for infantile/early-childhood-onset epilepsies when criteria are met (onset <5 years AND clinically severe seizures affecting daily functioning and/or interictal EEG abnormalities, etc.). While the patient meets the age requirement and WES was ordered, the record does not document the policy-required 'clinically severe' seizure features or EEG abnormalities; therefore the policy's explicit clinical criteria are not satisfied and the test is not covered per this policy.",15098,2122,17220
Case5674,rag,all_incorrect,iter1,WES,Patient plan states 'whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome.',No,"Policy's medically necessary criteria apply to patients with onset of seizures before age 5. The patient is 9 years old and no documentation of seizure onset before age 5 is provided, so age-related criterion is not met per policy.",Not Specified,The policy recommends genetic counseling and specialist evaluation but does not state a specific required ordering provider specialty for testing; the ordering provider being a general practitioner is not explicitly addressed as disqualifying.,No,"The policy's medical indication is infantile- or early-childhood-onset epileptic encephalopathy with onset before age 5 and clinically severe seizures and/or EEG abnormalities. The chart documents persistent seizures but does not document seizure onset <5 years or documented severe seizures/EEG criteria, so the patient does not meet the policy's specified clinical indications.",Not Specified,"The policy describes testing strategies (targeted gene testing, panels, CMA may be considered) but does not mandate specific prior tests before WES; although the patient had a nondiagnostic CMA, the policy does not require prior tests explicitly.",Not Specified,"The policy does not list family history or consanguinity as standalone coverage criteria for epilepsy genetic testing. The patient has a family history of sudden unexplained death (uncle), but the policy does not specify this as an eligibility criterion.",Not Specified,"The policy strongly recommends formal genetic counseling by experienced personnel but does not state genetic counseling as an explicit coverage precondition; the patient has had multiple genetic counseling visits and arranged genetics follow-up, which aligns with the policy's recommendation.",81415,Whole exome sequencing corresponds to CPT code 81415 (exome sequencing).,No,"Under the policy, testing is medically necessary for infantile- or early-childhood-onset epileptic encephalopathies with onset before age 5 and severe seizures/EEG abnormalities. The provided record documents a 9-year-old with persistent seizures but no documentation of seizure onset <5 years or the required severity/EEG criteria; therefore WES is not supported as medically necessary by this policy.",15072,2412,17484
Case9773,rag,all_incorrect,iter1,CMA,Patient information explicitly states a chromosomal microarray (CMA) was ordered to assess for genomic copy number changes.,Not Specified,"The provided WES/WGS policy does not specify age-based eligibility criteria for chromosomal microarray testing; age criteria in the document apply to WES/WGS, not CMA.",Not Specified,"The WES/WGS policy specifies ordering-provider requirements for WES (evaluation by a clinician with genetics expertise), but the policy text does not state ordering-provider requirements specific to CMA; the patient’s study was ordered by the oncologist.",Yes,"Per the policy's Benefit Application and WES policy text, specialized diagnostic genetic testing is covered when medically necessary to diagnose/manage an existing condition. The child has severe intellectual disability (a neurodevelopmental disorder) for which CMA is an appropriate diagnostic test and is referenced in the policy as part of standard genetic workup.",Not Specified,"The WES/WGS policy discusses prior testing (eg, CMA) as part of the standard workup before WES, but the policy does not define required prior tests before performing CMA itself; no required prior tests for CMA are specified.",Not Specified,"The policy lists family-history criteria relevant to WES (eg, developmental delay) but does not specify family-history or consanguinity criteria for CMA; the patient’s family history (maternal aunt with immunologic disorder) is not addressed in the provided text.",Not Specified,"The policy emphasizes that genetic counseling is recommended and requires counseling for WES, but it does not state counseling as a specific requirement for CMA. The patient did receive pre-test counseling, which aligns with policy recommendations.",Not Specified,The provided policy document does not list CPT codes for chromosomal microarray testing; none of the listed CPT options are identified in the policy as corresponding to CMA.,Yes,"Based on the policy's Benefit Application that 'Benefits are available for specialized diagnostic genetic testing when it is medically necessary to diagnose and/or manage a patient's existing medical condition,' and given the child’s severe intellectual disability for which CMA is an appropriate diagnostic test referenced in the policy as part of standard workup, the CMA is covered.",14847,2666,17513
Case18257,rag,all_incorrect,iter1,BRCA1/2,Patient is explicitly being evaluated for BRCA1/2 testing (history of breast cancer and statement that BRCA1/2 testing was ordered).,Not Specified,The provided Cigna hereditary cancer panel guideline does not state explicit age cutoffs for BRCA1/2 within the excerpt; it instead refers to a separate 'BRCA Analysis' guideline for BRCA-specific criteria.,Not Specified,"The policy requires pre- and post-test genetic counseling by an appropriate provider and that the rendering laboratory is qualified, but it does not specify an ordering-provider specialty requirement in the provided text (no prohibition of a general practitioner).",Yes,"The guideline defines a medical indication as 'Member has a personal diagnosis of cancer consistent with the hereditary cancer syndrome that is suspected' and the patient has a personal history of breast cancer (diagnosed ≤50), which is consistent with hereditary breast/ovarian cancer.",No,"The policy requires pre- and post-test genetic counseling by an appropriate provider as part of eligibility; there is no documentation of prior genetic counseling for this patient, so the counseling requirement has not been met.",No,"Family-history criteria are specified in the policy for certain scenarios, but the patient's documented family history (a sibling with short stature) does not include relevant cancers required by the guideline.",No,The guideline explicitly requires pre- and post-test genetic counseling by an appropriate provider for hereditary cancer testing and there is no documentation that counseling occurred.,Not Specified,"The provided policy maps hereditary breast cancer multigene panels to CPT 81432 (not listed among the offered options) and lists 81228 for chromosomal microarray; the excerpt does not map a single-gene BRCA1/2 CPT to any of the specific option codes provided, so none of the given codes can be confirmed from the policy text.",No,"Although the patient has a medical indication (personal breast cancer), the policy requires pre- and post-test genetic counseling and adherence to the BRCA Analysis criteria; counseling is not documented and BRCA-specific coverage is governed by a separate EviCore 'BRCA Analysis' guideline referenced but not provided, therefore coverage criteria are not met as documented.",11877,3821,15698
Case10075,rag,all_incorrect,iter1,CMA,Patient record explicitly states consideration of chromosomal microarray (CMA) testing; prior CMA testing is also mentioned. Basis: patient clinical information.,Not Specified,The provided BCBS_FEP WES/WGS policy addresses ‘‘children’’ and infants for WES/WGS but does not specify numeric age-based eligibility criteria for CMA. Basis: policy text does not define age criteria for CMA.,Not Specified,The WES/WGS policy specifies evaluator requirements for WES/WGS (evaluation by clinician with genetics expertise) but does not state ordering-provider requirements specific to CMA. Basis: policy text lacks CMA-specific ordering/provider requirements.,Not Specified,"The WES/WGS policy defines medical indications for exome/genome testing (eg, unexplained congenital anomalies such as meconium ileus) but does not provide explicit coverage/clinical criteria for CMA. Basis: policy addresses WES/WGS indications, not CMA.",Not Specified,"The provided policy references prior testing (eg, CMA) as part of WES/WGS criteria but does not state required prior-test protocols for CMA itself. Basis: policy text does not define prior-test requirements for CMA.",Not Specified,"The WES/WGS policy lists family-history items relevant to exome/genome sequencing (including inborn errors of metabolism), but it does not specify family-history criteria for CMA. Basis: policy addresses family history for WES/WGS, not CMA-specific criteria.",Yes,Policy states formal genetic counseling is recommended for most cases when genetic testing is considered and should be performed by an individual with experience. The patient had pre-test counseling with a genetic specialist and arrangements for post-test follow-up. Basis: 'Genetic Counseling' section of policy and patient facts.,Not Specified,The supplied BCBS_FEP WES/WGS policy document does not list or map CPT codes for CMA. Basis: policy text contains no CMA CPT code information.,No,"The only insurance policy provided is specific to WES/WGS. That policy does not provide explicit coverage criteria for CMA; while the Benefit Application states that specialized diagnostic genetic testing may be covered when medically necessary, there are no CMA-specific criteria in the provided policy to adjudicate medical necessity. On the evidence available (patient info + provided policy text only), coverage for CMA cannot be affirmed. Basis: absence of CMA-specific coverage criteria in provided BCBS_FEP policy document.",14844,3865,18709
